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ABSTRACT
This report presents an analysis of data collected on the health status of people in prison and prison health systems for 39 countries in the WHO 
European Region. The Health in Prisons European Database (HIPED) survey collected data from Member States between 2016 and 2017 to enable 
monitoring and surveillance of health in prisons. The aim of this report is to provide an indication of the current status of prison health in the European 
Region and highlight areas of prison health policy that should better be aligned to WHO guidance. The report presents data and recommendations 
under the following headings: prison population statistics, prison health-care systems, prison environment, risk factors for ill health, disease screening 
on admission, prevention of infection, treatment and mortality. These data, alongside WHO guidance on health in prison, will help to inform and 
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FOREWORD
It is said that no one truly knows a nation until one has been inside its jails. 
A nation should not be judged by how it treats its highest citizens, but its lowest ones.
Nelson Mandela 
Over the past 25 years, the WHO Health in Prisons Programme (HIPP) has advocated for improved health 
outcomes and equivalence of care for people deprived of their liberty, as health care should be of the same 
standard inside or outside prison. Individuals in prisons and other places of detention are a key population 
that must not be “left behind” in the pursuit of the United Nations Sustainable Development Goals and as 
part of the WHO initiatives of universal health coverage and improved health and well-being for all. 
For the majority of people in prisons, their custody experience is often for a short but disruptive period 
of time, and many find themselves caught in a cycle of disadvantage, crime and imprisonment. In most 
countries, very few people serve life sentences, so people in prison must be prepared for release back to 
the community, which includes addressing their health conditions. The deprivation of liberty is itself the 
punishment for crime; respect for human dignity and fundamental human rights must be observed at all 
times during imprisonment. 
During the time of incarceration, prisons become a “home” and “community” for the people living and 
working in these environments. It is through this lens that WHO continues to advocate with Member States 
and support them to ensure that this key population is not overlooked in public health agendas. Time spent 
in prison can be used by health services to address health issues that may not have been treated in the 
community due to a variety of barriers to access to health services and health inequities. Prison therefore 
must be seen as a health-promoting setting in which health interventions can address existing health 
conditions and contribute to positive lifestyle changes. Time in prison can also be used to improve skills that 
can help people find a job after release.
It is not, however, easy to provide health care in prisons, which by their nature are designed for safe custody 
and are operated with strict security regimes. Moreover, the prison service is often the least known and 
understood of all public services, despite its importance for keeping society safe. 
The groundbreaking work on health in prisons by the WHO Regional Office for Europe has demonstrated 
that improving the health of people in prison and integrating prison health into the overall public health 
agenda is an essential step towards improved well-being in general and reducing health inequities. 
Compared to individuals in the community, people in prison are characterized by a high prevalence of  
co-occurring health problems, often caused by significant social, environmental and economic determinants 
of health that occur throughout the life-course, both before and after incarceration. Governments are 
expected to give a degree of priority to health in prisons to meet their duty of care for those deprived of their 
liberty, as mandated by the United Nations Nelson Mandela and Bangkok Rules. 
The health of people in prison is of great importance for the WHO European Region and, indeed, globally, as 
it is estimated that 11 million people are held in custody across the globe at any one time and more than 30 
million people worldwide are thought to move between their communities and prisons annually. Yet people 
in prison generally are not included in public health data collections, so the true health needs of this key 
population are not highlighted to the same degree as populations within the community. 
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The Status report on prison health in the WHO European Region is an innovative initiative that illustrates 
the complex nature of health in prisons and represents a milestone achievement for the WHO HIPP. For the 
first time, WHO has been able to report on the health of individuals in custody, ensuring that the health 
status of this population is no longer missing from public health data. This work is essential to inform the 
implementation and evaluation of evidence-based prison health policies in the Region and ensure continued 
efforts to integrate prison health policy into the broader health promotion and public health agendas. 
It is through continuous monitoring and evaluation of the health status of people in prison and the health 
services delivered in places of detention that Member States can ensure that policies and practices for prison 
health services appropriately address the health needs of this population.     
Dr Piroska Östlin
WHO Regional Director for Europe a.i.
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PREFACE
It is estimated that 6 million people are incarcerated every year in the WHO European Region. The 
prevalence of many health conditions is much greater among people in prison, who very often represent 
those “left behind”, compared with individuals in the community. Prison and other places of detention can 
provide an opportunity to deliver preventive and risk-reduction interventions and treatments to a population 
that previously may have had limited or no access to health care and healthy living. A large proportion of 
people in prison return to the community every year, so it is a public health imperative that management 
and treatment for health conditions, particularly (but not exclusively) infectious diseases, are provided in 
the prison environment to prevent transmission within the community upon release. Prisons represent one 
of the settings for health promotion to ensure health and well-being and to achieve the United Nations 
Sustainable Development Goals. 
Many Member States of the WHO European Region are striving to improve the health of people in prison, 
but others do not manage completely to protect the health of those in detention. The WHO European health 
policy framework, Health 2020, and WHO’s 13th General Programme of Work aim to improve public health 
and reduce health inequalities, and highlight human rights and equity as being key to good governance for 
health. These principles must also apply to people deprived of their liberty. 
To improve the health of those in prison, it is essential to have a complete understanding of the 
complexities of the health status of this population and the services that exist to care for them. By 
addressing the health needs of individuals during their time in prison, it is possible also to have a positive 
impact on the health of their families and wider communities upon release from prison. Treatment of 
communicable diseases in prison contributes to reduced transmission in the community, and promotion of 
healthy lifestyles targeting noncommunicable disease risk factors can lead to sustained healthy behaviours 
that continue after release. 
The Status report on prison health in the WHO European Region is the first report on prison health by 
WHO worldwide. It reveals that the general state of monitoring and surveillance systems for health in prisons 
in European Member States is poor. Most countries were not able to provide valid responses for many of 
the database indicators. Without this information, policy-makers will not be able to develop evidence-based 
policies that effectively target the needs of the prison population. This report therefore recommends that 
Member States should improve their national data-collection systems to ensure that the health status of 
people in prison is fully understood and services that improve the health outcomes of this population are 
delivered. 
In line with what is generally known about the health of people in prison, data from the Health in Prisons 
European Database (HIPED) paint a picture of an extremely vulnerable population that suffers from poor 
health and engages in risky health behaviours, leading to noncommunicable and communicable diseases 
and mental health conditions. Prevalence of indicators such as tobacco-smoking, injection drug use and 
bloodborne viruses is shown to be much higher than generally is seen in the community. Furthermore, a 
large proportion of deaths in custody were found to be from suicide, which emphasizes the urgent need 
for Member States to safeguard the lives of individuals in their care by ensuring that prison health systems 
have appropriate screening and treatment for mental health disorders and suicide risk both on reception to 
prison and throughout an individual’s stay in custody. 
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It is hoped that the data and recommendations in this report will support Member States to improve their 
surveillance systems to allow better monitoring of the health status of people in prison, while providing 
insights into preventive activities and care. Through evidence-based policies, the WHO European Region 
can strive significantly to reduce health inequities and achieve equivalent health outcomes for this key 
population, ensuring no one is left behind. 
Dr Bente Mikkelsen
Director of the Division of Noncommunicable Diseases and Promoting Health through the Life-course 
WHO Regional Office for Europe
Dr João Breda
Head of the WHO European Office for the Prevention and Control of Noncommunicable Diseases 
WHO Regional Office for Europe 
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EXECUTIvE SUMMARY
BACKGROUND
On any given day, more than 1.5 million people in the WHO European Region are incarcerated (1). 
The health profile of people in prison is one of complex, co-occurring physical and mental health 
conditions (2), and the poor health status of this population is typically set against a backdrop of 
entrenched and intergenerational social disadvantage. Risk factors for poor health overlap with risk 
factors for incarceration (3), such as substance use, unstable housing and low educational attainment (4). 
Incarceration and the process of transitioning back into the community following release also impact on 
health, and continuity of care between health services in prisons and the community is often lacking.
The field of prison health covers both the health status of individuals in prison and the organization 
of prison health systems and services. Prison health must be recognized as a broader public health 
issue, as most people who are incarcerated will return to the community, usually after a relatively short 
prison sentence. Many people return to prison due to reoffending, and this cycle between prison and 
community can lead to disjointed and ineffective health care. The benefits of health services delivered 
(and the consequences of inadequate health-service delivery) in prison are often only realized after 
individuals return to their communities. Lack of adequate health care in prisons and detention centres 
frequently requires community health services and hospitals to intervene, at considerable cost, when 
an individual’s physical or mental health problems become acute following release from prison. In the 
initial period following release from custody, individuals have an increased risk of suicide, self-harm and 
drug overdose, meaning continuity of care during this transition is essential. This has significant public 
health implications and can constrain a country’s capacity to address health inequalities systematically.
The prison population, with its disproportionate disease burden, is one that cannot be forgotten in 
WHO’s pursuit of the United Nations Sustainable Development Goals (SDGs). To achieve universal 
health coverage and better health and well-being for all, and as part of the WHO 13th General 
Programme of Work, it is vital that prisons are seen as a setting for health promotion and an 
opportunity to change lifestyles to ensure that “no one is left behind”.
The importance of prison health being part of public health has been articulated in various international 
statements, including the WHO Trenčín Statement (5), the WHO Moscow Declaration on Prison Health 
as Part of Public Health (6), the WHO conclusions of the international meeting on prisons and health 
(Lisbon, 2017) (7) and the Helsinki Conclusions (2019) (5,7). This link between prison health and public 
health means that prison health-care governance and continuity of care between prisons and the 
community are of crucial importance.
Good prison health-system governance has important implications in addressing health inequity, 
improving the health of broader communities and improving health care in prisons. Despite the 
importance of effective health services and systems in prisons to addressing health issues and 
inequalities, in most countries, very little is known about these systems. Mapping existing prison health 
systems in Europe, including the level of provision, implementation and quality of health care, is the 
main aim of the Health in Prisons European Database (HIPED). This is a critical first step for:
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• providing the basis for the development of evidence-informed policies for prison health systems and 
services in Europe, including the relationship with broader policies relating to health inequalities and 
universal health coverage;
• capacity-building for collaborations relating to prison health systems; and
• identifying target areas for strengthening of health information systems and prison health services, 
which has implications for strengthening continuity of information flow with community health 
information systems and contributing to continuity of care.
Established in 1995, the WHO Regional Office for Europe Health in Prisons Programme (HIPP) is 
committed to addressing the health needs of people in prisons. Given that people in prison typically are 
excluded from population health data collections, WHO HIPP has recognized the need for comparable 
data on the health of people in prison, and on prison health governance, systems and administration. 
The availability of these data is an essential component in the monitoring of prison health-system 
performance, and ultimately can be used to improve health services in prisons and reduce health 
inequalities.
To bridge the gap between evidence and policy, WHO HIPP led the development between 2014 and 
2016 of the WHO Minimum Public Health Dataset for Prison Health survey on the health of people in 
prison and the health systems and services that exist to serve this population. The data collected from 
the survey comprise the Health in Prisons European Database (HIPED), which represents one of the first 
attempts to provide comparable data on prison health systems in the WHO European Region and lays a 
foundation for future work to generate comprehensive and comparable data on prison health in Europe 
and globally.
METHODOLOGY
A preliminary pilot survey was completed by the United Kingdom and Portugal in 2016 to assess and 
refine the survey instrument. Following this pilot, in 2016 and 2017, national focal points from the 
53 Member States of the WHO European Region were invited to complete the WHO Minimum Public 
Health Dataset for Prison Health survey on prison health systems and services in consultation with their 
prison health authorities.
Data for the 39 countries that completed the survey data-collection process were launched online in 
January 2018 via the Global Health Observatory (8).
This report presents aggregate data for key indicators of the eight domains of the HIPED:
• prison population statistics
• prison health systems
• prison environment
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KEY FINDINGS
PRISON POPULATION 
• Few Member States were able to provide data on different population cohorts within prison:
• only 16 Member States were able to report on the percentage of people in prison over the age  
 of 55 years; 
• only eight were able to report on the percentage of people in prison from an ethnic or racial 
 minority; and 
• nine were unable to report on the number of women in their prison system.
PRISON HEALTH-CARE SYSTEMS AND GOvERNANCE
• The Ministry of Justice was the authority most frequently holding responsibility for health-care 
service authority, administration of the health-care service budget and health-care service funding.
• Fewer than 50% of countries reported the Ministry of Health or other health-care authorities as 
being responsible for the assessment of prison health systems.
• Fewer than 60% of countries reported the Ministry of Health or other public health authorities as 
being responsible for the inspection of hygiene, nutrition and living conditions.
• Eighteen Member States reported that people in prison must cover some of their own health-care 
expenses. 
• While most countries reported links between prison and community health-care systems, 
information about the nature of these links is limited.
 PRISON ENvIRONMENT
• Most countries reported that smoke-free cells were available in prisons.
• Just over half of the countries reported that drug-free units were available in prisons.
• The vast majority of countries reported that the production of meals in prisons occurs in centralized 
kitchens, with few countries reporting that self-cook kitchen areas were available.
DISEASE SCREENING AND TREATMENT
• Most countries reported having implemented WHO guidelines regarding mental health screening, 
substance use treatment and non-mandatory screening for bloodborne viruses (BBVs) and sexually 
transmitted infections (STIs). 
• Some countries, however, reported that key screening processes or substance use treatments were 
unavailable, or that mandatory screening practices were in place for BBVs and STIs.
• Fourteen per cent of Member States reported that they do not screen for severe mental health 
disorders on or close to reception. 
• Forty-one per cent reported that they do not screen for harmful use of alcohol on or close to 
reception: of the Member States that do screen, only 47% use a validated screening tool. 
• Thirty-one per cent do not screen for oral health issues on reception to prison.
RISK FACTORS FOR ILL HEALTH
• Data on prevalence of diseases and risk factors generally were missing:
• only five Member States were able to report on the prevalence of injection drug use among 
 people in prison; 
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• the number of Member States able to report on the prevalence for noncommunicable disease 
 risk factors was extremely low – only one country reported on the prevalence of obesity, three on 
 overweight, five on tobacco-smoking and eight on high blood pressure; and 
• only 10 countries provided prevalence data on tuberculosis in prison, 11 on HIV, 11 on hepatitis C 
 and eight on hepatitis B.
PREvENTION
• Resources for the prevention of infectious diseases are not universally available across European 
prison health systems, and a number of countries reported that such resources are entirely 
unavailable.
• Only six countries reported that needle or syringe exchange programmes were available in some  
or all prisons.
• A full vaccination course for hepatitis B is not available in prisons in 31% of Member States.
TREATMENT 
• Most countries reported that access to mental health support delivered by health staff in prisons 
existed, but just over half stated that national guidelines exist for the treatment of severe mental 
health disorders in prisons.
• Fewer than half of countries reported that national guidelines exist for the prevention of drug-
related deaths in prison, and 19% of Member States currently do not offer opioid substitution 
therapy in prison.
MORTALITY 
• Of the reported numbers of deaths in custody, 13.5% were from suicide, and the suicide rate was  
6.5 per 10 000 incarcerated people.
• The mortality rate for men in prison was higher than that for women.
LIMITATIONS
There were substantial limitations in the availability of the data across many indicators, notably for 
the prevalence of health risk factors and substance use on admission to prison, for which up to 97% of 
countries (n = 38) reported that they had no national data for indicators, or did not respond or provide 
a valid response (meaning their data were missing). This may be because some countries do not collect 
these data at national level or perhaps due to inconsistencies between the HIPED indicators and the 
countries' data-collection processes and systems.
Comparisons of conditions and risk factors between the incarcerated population and the community 
at large cannot easily be made with these data. Age-, sex- and social-class-adjusted rates would be 
necessary to enable sound conclusions to be drawn.
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CONCLUSIONS
The HIPED represents a milestone, as it is one of the few data-collection initiatives designed to gather 
comprehensive and comparable data on prison health systems from a region across key domains of 
prison health-care governance systems and health-care services. While there are limitations to the 
HIPED data, the collection of these data is an important prerequisite to developing evidence-based 
policy for prison health systems and services in the European Region and a promising step in informing 
future work to collect data on prison health in the European Region and internationally. The HIPED is a 
necessary tool for WHO and Member States to ensure that “we leave no one behind,” including those in 
prison, in the pursuit of the SDGs.
This report summarizes key findings from the HIPED and provides recommendations for Member States 
to encourage alignment to WHO guidelines and to improve data-collection and reporting ultimately to 
inform the improvement of prison health systems. The recommendations are compiled in Chapter 6.
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STATUS REPORT ON PRISON HEALTH IN THE WHO EUROPEAN REGION 
1.1 THE EUROPEAN PRISON POPULATION
Incarceration across the WHO European Region is best understood as part of a more complex global 
picture. The global prison population exceeds 10.7 million people and is growing at a rate faster than 
population growth (1). On any given day, more than 1.5 million people in the WHO European Region 
are incarcerated (1). Countries in the WHO European Region account for approximately 15% of the 
global prison population, and the incarceration rate across the Region (187 per 100 000) is around 1.3 
times greater than the global average (145 per 100 000) (1). The European Region is the only region 
that has seen a fall in the number of incarcerated people since 2000, with a decrease of 22% (1). This 
reflects large decreases in eastern European and central Asian countries. In contrast, the number 
of people incarcerated has increased 6% in western Europe, 12% in northern Europe and 27% in 
southern Europe (2). Incarceration rates and the static prison population sizes of regions within Europe 
are summarized in Fig. 1.
No reliable global or regional estimates of annual prison throughput exist, but the United Nations 
estimated in 2008 that more than 30 million adults pass through prisons globally each year (3). In many 
countries in the European Region and internationally, most prison sentences are relatively short and a 
large number of people in custody are unsentenced (in pre-trial detention) (4), such that the annual prison 
throughput is larger than the daily number of people who are incarcerated (4).
Consistent with global trends, the number of prison entries in many European countries is substantially 
greater than the total daily number of people in prisons (4). The lack of routine reporting on annual 
dynamic prison populations can be said to perpetuate the misconception that prison populations are 
small and static, and hides the fact that the vast majority of people in prison return to the community, 
usually after a relatively short period of time in custody.
a The regions of Europe are as follows. Europe/central Asia: Armenia, Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, Russian Federation, Tajikistan, Turkey, Turkmenistan and Uzbekistan. Central and 
 eastern Europe: Belarus, Bulgaria, Czechia, Hungary, Republic of Moldova, Poland, Romania, Slovakia and Ukraine. Western Europe: Austria, Belgium, France, Germany, Liechtenstein, Luxembourg, 
 Monaco, Netherlands and Switzerland. Northern Europe: Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden and United Kingdom. Southern Europe: Albania, Andorra, 
 Bosnia and Herzegovina, Croatia, Cyprus, Greece, Italy, North Macedonia, Malta, Montenegro, Portugal, San Marino, Serbia, Slovenia and Spain: also Kosovo (all references to Kosovo in this document
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Fig. 1. Incarceration rates and prison population sizes in Europea, 2018







1.2 THE HEALTH PROFILE OF PEOPLE IN EUROPEAN PRISONS
There is overwhelming evidence that people involved in the criminal justice system disproportionately 
experience complex, co-occurring health problems. These include mental illness (5), substance 
dependence (6,7), cognitive disability (8), HIV/AIDS, hepatitis A, B and C, tuberculosis (TB) and related 
communicable infections (9), and noncommunicable diseases (NCDs) (10). The epidemiology, prevention 
and treatment of NCDs in prisons has largely been neglected; most evidence about the health of people 
involved in the criminal justice system in Europe typically concerns communicable diseases, highlighting 
considerable regional differences between western Europe compared with eastern Europe and central 
Asia in the prevention and treatment of infectious diseases (9).
The mortality rate for people released from prison far exceeds that of the general population, 
particularly in the month following release, and primarily due to preventable causes such as suicide, 
injury and drug overdose (11,12). Mortality rates following release from prison are more than twice as 
high in some eastern European countries than in western, with some European countries reporting 
mortality rates of up to 500 deaths per 100 000 people (13).
The poor health experienced by people with histories of criminal justice involvement is associated with 
their exposure to health risk behaviours and environments. Common risk factors for communicable 
diseases that are greatly overrepresented in this population include injection drug use, unprotected 
sexual activity, unsterile piercing and unsterile tattooing (7,14). Similarly, risk factors for NCDs, including 
high rates of smoking, poor diet and insufficient physical activity, are overrepresented in prison 
populations (10,15). Relapse to health-risk behaviours, such as substance use and harmful use of alcohol, 
is common following release from prison and can contribute to the poor health outcomes and high 
mortality rates in this population (13).
People with histories of criminal justice involvement typically experience and are exposed to a range of 
poor social, economic and environmental determinants of health that are linked to low socioeconomic 
status and social exclusion (16). Women in prison suffer disproportionately from a range of physical and 
mental disorders. They comprise a rapidly increasing proportion of the prison population and have 
markedly high levels of exposure to a range of poor social determinants of health, including domestic 
violence, sexual abuse, trauma, adverse childhood experiences, homelessness, substance use and 
mental health disorders (17,18). People from ethnic and minority groups and young and older people 
also have specific health and social care needs that require tailored support in prison (19,20).
1.3 PRISON HEALTH AS A PART OF PUBLIC HEALTH
While the health of incarcerated people is important in its own right, prison health is also a concern for 
broader society, as prisons are linked closely to communities. The majority of people in prison return to 
the community, and many people move repeatedly between both settings (21).
Addressing the health of people in prison not only improves the well-being of individuals, but also has 
impacts on families and wider communities (22). As articulated in the WHO Trenčín Statement (23), the 
WHO Moscow Declaration on Prison Health as Part of Public Health (24), the WHO good governance 
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for prison health policy brief (25) and the conclusions of the WHO international meeting on prisons and 
health in Lisbon in 2017 (26), the health of people in prison is a critical part of broader public health. 
Addressing the health of people in prisons is closely aligned with the global United Nations Sustainable 
Development Goals (SDGs) and the WHO 13th General Programme of Work (27) to ensure no one is left 
behind.
In some cases, the health risks and problems experienced by people in prison may be worsened during 
incarceration by unhealthy conditions of imprisonment, such as overcrowding, lack of fresh air and 
natural light, clean sanitary facilities or means for personal hygiene, inadequate nutrition and exposure 
to violence (15). In other cases, however, incarceration can provide low-threshold access to health 
services for people who often face substantial barriers to accessing health care in the community (21). As 
such, prisons can be a setting for health promotion and an environment in which to provide equitable 
health care to people experiencing significant barriers to access. Prison can also provide important 
aspects of a settings-based approach to health promotion, health education and disease prevention.
It is important that people involved in the criminal justice system receive health care without 
interruption at all stages of detention, including in police and pre-trial detention, in prison, during 
institutional transfers and following release from prison (25).
1.4 WHAT IS UNDERSTOOD BY PRISON HEALTH SYSTEMS
According to WHO, health systems consist of all organizations, people and actions whose primary intent 
is to promote, restore or maintain health (28). The WHO definition of prison health systems includes 
six key building blocks: service delivery; health workforce; information; medical products, vaccines 
and technologies; financing; and leadership and governance (28). Prison health systems have several 
core components, reflecting the functions of health systems more generally, including: prison health-
care governance arrangements; the screening, treatment and prevention of both communicable and 
noncommunicable diseases; rehabilitation; health promotion; and health information.
Guidelines for appropriate and effective prison health services are discussed in more detail in the WHO 
prisons and health guidance document (15). Key principles include: screening and treatment for mental 
health disorders, substance use disorders, oral health disease and TB; the availability of non-mandatory 
testing for bloodborne viruses (BBVs) and sexually transmitted infections (STIs), with appropriate 
pre- and post-test counselling; the provision of materials that reduce the risk of communicable 
diseases (such as condoms, lubricants and disinfectants); and the implementation of harm-reduction 
programmes, including needle and syringe exchange programmes.
Effective health services and systems in prisons are central to addressing health issues and 
inequalities, yet in most countries very little is known about them. Improving prison and detention 
health services depends on effective collection and use of information to inform policy, resource 
allocation and expenditure, and to enable evaluation of services and interventions. The available data 
on the health of people in prisons and correctional health services in prisons are scarce and subject to 
large methodological differences, highlighting the need for standardized survey instruments for prison 
health systems.
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To address these issues and bridge the evidence gap, a number of surveys have been conducted in the 
past two decades to collect data about prison health systems, services and environments across European 
countries. Past data-collection efforts include surveys on prison population demographics and the prison 
health system workforce (4), mental health systems (29,30), TB control (31), and the prevalence of BBVs, 
substance harm-reduction and treatment systems (32). Regional survey efforts have generally found high 
prevalence of illness and variations in services, but only limited conclusions about prison health systems 
and services at regional level can be drawn due to shortcomings in sampling and limited data collection 
on a broad range of health conditions and risk factors.
Evidence on the organization of, and screening, 
treatment and prevention in, European prison 
health systems is subject to considerable 
limitations. There appears to be considerable 
diversity across Europe in how these 
different health-system elements operate 
in prison settings, but few conclusions 
can be drawn about them. Most of 
the information collected focuses on 
communicable diseases and is subject 
to issues regarding comparability. 
There is a significant dearth of 
knowledge about NCDs, excluding 
mental health and substance use; very 
little is known about the epidemiology 
of these issues in this population across 
Europe, let alone the systems and 
services that exist to respond to them (33).
Significant amounts of data on health in 
prisons are substantially out of date, which is 
important to recognize given recent and ongoing 
changes in governance and organization of health systems 
across the European Region. Additionally, most of the available 
evidence is generated from high-income countries, with the paucity of information about low- and 
middle- income countries being widely noted (19).
1.4.1 THE INTERFACE OF PRISON HEALTH SYSTEMS WITH LARGER PUBLIC HEALTH SYSTEMS
The WHO Good governance for prison health in the 21st century policy brief (25) recommends that prison 
health services be independent of prison administration, integrated into national health policies and 
systems, and not involved in punishment. The conclusions of the WHO Health in Prisons Programme 
(HIPP) international meeting on prison health held in Lisbon in 2017 (26) highlighted that treatment and 
prevention programmes restricted to prison settings are unlikely to have sustained benefits for people 
experiencing imprisonment, underscoring the need to improve continuity of care between prison public 
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The connection between prison health services and general public health administration varies 
substantially across the European Region (34). In some European countries, there is little or no 
cooperation between the administrations of prisons and health authorities. In other countries, health 
authorities are requested at a minimum to conduct the inspection and supervision of hygiene or the 
licensing and accreditation of health-care facilities and health-care personnel in prisons (35).
Ministries of justice are responsible for the health services provided to people in prison in most 
European countries, but in some, prison health care has partially been integrated within the national 
health system, as recommended by WHO guidelines. A number of other countries have commenced 
the transfer of prison health-care responsibility and administration to the national health system and 
Ministry of Health. European countries that have implemented a complete transition to ministries of 
health include Finland, France, Norway, Slovenia, Italy and the United Kingdom; regions of countries 
that have completed the transition include the Swiss cantons of Geneva, Vaud, Valais and Neuchatel, 
and Catalonia in Spain (15,35).
1.5 THE IMPORTANCE OF MAPPING THE EXISTING PRISON HEALTH SYSTEMS 
IN EUROPE FOR IMPROvING POLICY AND PRACTICE FOR PRISON HEALTH
More information is needed to have a complete picture of existing European prison health systems 
and how they compare with each other. Past surveys have noted issues regarding standardization of 
data collection across countries, limitations in knowledge on availability and coverage of health-care 
services, and differences in the interpretation of questions across countries. More information also is 
needed about prison health data-collection processes and any challenges faced by Member States in 
collecting these data.
Assessment and evaluation of prison health conditions and services are also lacking because of the 
absence of the prison population from many national health statistics and the widespread absence 
of health data collected as part of prison statistics (25). This is a basic and common shortcoming 
of prison health systems’ dialogue with national health authorities. In the absence of reliable and 
continuous baseline data on the health of people in prison and existing health services and systems, 
efforts to assess the performance of prisons in addressing the health needs of people incarcerated in 
the WHO European Region are limited.
1.5.1 THE HEALTH IN PRISONS EUROPEAN DATABASE AS A TOOL FOR MAPPING PRISON 
HEALTH SYSTEMS
The Health in Prisons European Database (HIPED) attempts to complete a comparable, regional data 
collection of prison health systems and services.
Funded by the Finnish Ministry of Social Affairs and Health, the WHO Regional Office for Europe HIPP 
commenced work on the HIPED between 2014 and 2016 to develop the WHO Minimum Public Health 
Dataset for Prison Health survey on prison health systems and services. Partners involved in this process 
included the HIPP Steering Group, which comprises the United Kingdom Collaborating Centre for the 
WHO HIPP (supported and hosted by Public Health England), the European Monitoring Centre for Drugs 
and Drug Addiction, the United Nations Office on Drugs and Crime, AFEW International, the European 







Federation for Prison Health, the International Committee of the Red Cross, Penal Reform International, 
representatives from the Netherlands, Slovenia, Spain and Switzerland, the European Centre for Disease 
Prevention and Control, and the Pompidou Group of the Council of Europe.
The questionnaire and data-collection process for the national questionnaire for the Minimum Public 
Health Dataset for Prisons in the WHO European Region was discussed with Member States during the 
WHO HIPP annual meeting on prison health held in Kyrgyzstan in late October 2015.
During 2016 and 2017, the WHO Regional Office for Europe invited national focal points from the 53 
Member States of the WHO European Region to complete the survey in consultation with their prison 
health authorities. Data for the 39 countries that completed the survey data-collection process were 
launched online in January 2018 via the Global Health Observatory (36). 
The aim of this work was to fill critical gaps in what is known about health systems and services for 
people in prison and to expand the evidence base in this important and under-researched area. The 
purpose of the survey was to establish a body of knowledge and evidence on prison and detention 
health systems comparable across countries in the European Region through collection, analysis and 
sharing of data.
This report summarizes key findings from the HIPED and provides recommendations for Member States 
to encourage alignment to WHO guidelines and to improve data collection and reporting ultimately to 
inform the improvement of prison health systems. The intention is to demonstrate the feasibility of the 
process, set a benchmark for future data collection and reporting processes, and inform future iterations 
of the survey to enable progressive improvement in the quality of the data. It also represents a key step 
in developing a comparable and sustainable monitoring and surveillance system of health in prisons.

  2.1 HIPED indicators
  2.2 Data collection, validation and cleaning
  2.3 Data presented in the report
2. 
METHODS
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The HIPED comprises data that were collected as part of a regional cross-sectional survey of 39 
European countries between 2016 and 2017. This report summarizes key indicators included in the 
WHO Minimum Public Health Dataset for Prison Health survey. The data for all indicators are available 
in the HIPED, which is subject to continuous updating to ensure that the data presented are as accurate 
as possible.
2.1 HIPED INDICATORS
The HIPED comprises 90 indicators across eight domains. A summary of domains and indicators is 
presented in Table 1, and a complete list of the indicators is available in Annex 1.




Seven indicators  
Example: total number of incarcerated people, total capacity of prisons, number 
of people belonging to subgroups (female, youth, senior and ethnic/minority 
individuals)
2. Prison health systems Twenty-one indicators  
Example: prison health-care authorities, the obligation of people who are 
incarcerated to cover health-care costs, prison and health workforce statistics
3. Prison environment Three indicators  
Example: availability of smoke-free cells and availability of different food systems
4. Risk factors for 
 diseases 
Twelve indicators  
Example: prevalence of smoking and obesity, testing protocols
5. Disease screening Forty-three indicators 
Example: screening, proportion of individuals tested for HIV, availability of mental 
health disorder screening
6. Prevention of 
 communicable 
 diseases 
Sixteen indicators  
Example: availability of disease-prevention programmes, such as needle 
exchange, availability of drug-free units
 7.  Treatment of  
 communicable and  
 noncommunicable 
 diseases 
Eight indicators  
Example: number of people receiving opioid substitution therapy (OST), number 
of people receiving HIV and hepatitis C treatment, availability of mental health 
support
8. Mortality Five indicators 
Example: total number of deaths, number of deaths of people under  
18 years of age, number of deaths by suicide






2.2 DATA COLLECTION, vALIDATION AND CLEANING
2.2.1 DATA COLLECTION
Letters of invitation were sent to WHO focal points in the Ministry of Health of 53 Member States during 
2016, with responses received from 41. Where prison health services are not under the authority of the 
Ministry of Health, invitations were forwarded to the responsible ministry (such as justice or interior). 
A complete list of the participating Member States is available in Annex 2. 
Overall, 39 countries completed the entire survey data-collection 
process, giving an overall response rate of 77%. The response 
rate means that the data are not generalizable across 
the entire European Region, as outcomes from this 
report may be skewed towards the countries that 
responded.
Between October 2016 and August 2017, 
the national focal point nominated by the 
relevant ministry from each participating 
Member State submitted the survey to 
the WHO Regional Office for Europe, 
liaising with other national experts, 
agencies or ministries as required. 
The survey was conducted using 
Qualtrics® Survey Software. Given 
the multisectoral consultation often 
involved in this process, a number of 
focal points completed the questionnaire 
electronically, exported into Microsoft® 
Word, or completed printed copies of the 
survey. Reflecting what is known about prison 
health governance arrangements, most key survey 
contacts were from ministries of justice, corrections, 
home affairs or subsidiary organizations (n = 21). While a 
number of countries provided some information about different 
experts and sectors consulted for the survey data collection, the processes 
regarding data collection from information sources at national level for the purposes of this survey were 
not well established.
2.2.2 DATA CLEANING AND vALIDATION
The first phase of data validation occurred between May 2017 and September 2017 and the second 
in February 2018, following the initial production of the prison country profile fact sheets (37). In both 
phases, focal points were contacted to provide clarification regarding missing or inconsistent data. Data 
cleaning began in August 2017 and the data have since been subject to ongoing data-cleaning and 
validation processes. Data validation has been conducted in cooperation with the national focal points. 
Out-of-range values were identified and were dealt with on a case-by-case basis when time and 
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resources permitted. Where it was not possible to address discrepancies in the data individually, they 
were resolved through logic checks. In the rare instances where these issues could not be resolved, the 
conservative approach of not reporting data for that indicator was adopted.
2.3 DATA PRESENTED IN THE REPORT
The response "No national data" refers to responses for which Member States indicated that they do 
not have data for the indicator of interest or in the format required by the HIPED. “No national data” is 
also used in instances where Member States with a federal structure indicated that they do not have 
data available for all jurisdictions. "Missing" refers to data that were not provided and for which no 
explanation was given, or to data that were identified as out-of-range and that could not be resolved 
through logic checks. "Not applicable" refers to responses that did not apply to Member States based 
on a previous response.
A number of countries, including those that reported "No national data" where data were not available 
in the HIPED format, provided more detailed information for indicators in comment variables online in 
the HIPED.
2.3.1 CALCULATIONS
The incarceration rates per 100 000 people for each year (2014, 2015 and 2016) were calculated 
using the total daily number of incarcerated people collected by this survey and total population data 
obtained from the World Bank Open Dataset (38).
The percentages of people who are unsentenced, female, under 18 years of age or over 55 years 
of age were calculated using the total daily number of each subgroup and the total daily number 
of incarcerated people. Similarly, occupancy levels were calculated using the total daily number of 
incarcerated people and the total daily capacity as the numerator and denominator respectively.
Ratios of prison staff and health-care staff per 1000 people incarcerated were calculated using the 
average daily number of total staff and the total daily number of people incarcerated from the same 
calendar year. The mortality rate per 10 000 people in prison was calculated using death data and total 
daily number figures from the same calendar years. Similarly, the percentage of deaths from suicide 
was calculated using suicide death data and total death data from the same calendar years. Across 
these indicators, where countries did not provide data for both the indicator and total daily number for 
the same calendar year, their data were excluded from these calculations.
2.3.2 METHODOLOGICAL CONSIDERATIONS
A number of participating Member States are federations, which in some cases led to the reporting of 
data at subnational level. Solutions to this were determined on a case-by-case basis. Where possible, 
the way in which subnational data were presented was determined in collaboration with national focal 
points. Where this was not possible, responses were coded as “No national data”. In the instances 
where data submitted present results of a research study or a survey using a representative sample, 
this has been noted as “No national data”, with the information available in the HIPED.
 3.1 Prison population
 3.2 Prison health-care systems
 3.3 Prison environment
 3.4 Risk factors for ill health
 3.5 Disease screening on admission
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The findings presented here are limited to the countries that provided data for each indicator. Data 
might be unavailable for countries because they reported that no national data were available, 
or because no valid response was provided. Details of missing data are provided in Annex 3. The 
countries reporting available data for prevalence indicators are outlined in Annex 4 and a list of 
countries providing responses in this report, including data for calculations, is available in Annex 5.
For some indicators regarding prevalence of testing or illnesses, the reference group used for 
prevalence estimates varied between countries; these are summarized in Annex 4. For example, 
some included all people who are incarcerated, and some included sentenced people only. Some 
countries also specified different groups to which these data referred. As a result, these factors may 
affect the prevalence estimates provided.
3.1 PRISON POPULATION
3.1.1 RATES OF INCARCERATION
The incarceration rate per 100 000 people between 2014 and 2016 across Member States (n = 32) 
declined slightly, from 183 in 2014, to 175 in 2015, and 166 in 2016. Of the 30 countries that provided 
sufficient data to calculate overcrowding in 2016, nine (23%) reported capacity levels over 100%. The 
range of capacity levels was 44–114%, with a mean of 90%.
WHO guidance
WHO recommends that overcrowding should be avoided in prisons, as it can lead to the accelerated spread 
of communicable disease such as HIV and TB, restricts the opportunity for physical activity and negatively 
impacts on mental health (15).
3.1.2 POPULATION GROUPS
Twenty-two per cent of the prison population are unsentenced/on remand (n = 26 countries) (Fig. 2) 











Fig. 3. Gender distribution







WHO recommends that health services must recognize women’s gender-specific needs and gender-sensitive 
training for the health-care needs of women in prison should be widely available in all prison systems (15).
One per cent of the prison population is under the age of 18 (n = 29 countries) (Fig. 4), and 5% are over 
the age of 55 (n = 16) (Fig. 5).
WHO guidance
Treatments and interventions for children and adolescents must respond to the different manifestations of 
poor mental health displayed by this group compared to adults (15).
WHO guidance
Older people in prison may typically have chronic and multiple health problems, including heart and lung 
problems, diabetes, hypertension, cancer, Alzheimer’s disease, Parkinson’s disease, ulcers, poor hearing and 
eyesight, memory loss and a range of physical disabilities. As a result, older people are likely to require a 
number of health-care services, including medical, nutritional and psychological treatment. The health care 
of older people in prison therefore necessitates the engagement of a multidisciplinary team of specialist 
staff (15).
Thirty-three per cent of the population are of a racial or ethnic minority (n = 8) (Fig. 6).
WHO guidance
The specific needs of ethnic minorities must be taken into account during treatment and development of care 














Fig. 5. Over 55 years of age
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3.1.3 DISCUSSION AND RECOMMENDATIONS
Overall, these data appear to be consistent with what is currently known about the European prison 
population. The total proportion of women reported in the survey was 6.3%, similar to a recent 
regional estimate of 6.1% (39). The percentage of countries that reported overcrowding (23%) was like a 
survey of 47 Member States conducted by the Council of Europe, which reported that 29% of countries 
experienced overcrowding (4).
Fewer than half of countries (41%) were able to provide any information about people over the age of 
55, and just one fifth (21%) were able to provide any information about people from ethnic or minority 
backgrounds. As such, there are substantial limitations in how these data can be interpreted. 
Report recommendations – prison population
Recommendation 1. Member States should ensure that data are collected on the number of people 
entering and leaving prison, and demographics of people in prison. Health services in prisons must reflect the 
specific health needs of the population, based on formal health needs assessments.
3.2 PRISON HEALTH-CARE SYSTEMS
3.2.1 PRISON HEALTH-CARE SERvICE AUTHORITIES
The responsible authorities for prison health-care services as indicated by countries are presented 
in Fig. 7. Most countries (n = 28) reported a single responsible authority for prison health-care 
services, while 11 (28%) reported that a combination of authorities are responsible for prison health 
care, meaning that more than one authority (two government ministries, for example) had a role in 
organizing prison health care . The Ministry of Justice is the most common sole authority of prison 
health services (44%), followed by the Ministry of Health (18%) and the health-care department of the 







Fig. 6. Racial or ethinic minority







The role of the ministry responsible for health should be strengthened in the domain of quality assessment 
of hygiene, health care and organization of health services in custody, in accordance with national 
legislation. A clear division of responsibilities and authority should be established between the ministry 
responsible for health or other competent ministries, which should cooperate in implementing an integrated 
health policy in prison (25).
Regardless of which ministry is responsible for prison health, authorities must ensure that (25):
1. international regulations and recommendations on prison health and medical ethics should be 
integrated into national law;
2. people in prison should have the opportunity to submit requests and complaints to prison authorities 
and the right to appeal to an independent authority without facing any negative consequences; and
3. government agencies should regularly inspect prisons to assess whether they are being administered in 
accordance with the requirements of national and international law, and independent bodies that are 
legally entitled to visit prisons and whose findings should be published should monitor prison conditions 
and the treatment of people in prison.
3.2.1.1 Role of Ministry of Health and other public health authorities 
Of the 37 countries providing data, 44% reported that the Ministry of Health or other public health 
authorities are responsible for the assessment of prison health-care services, 60% that they are 
responsible for the inspection of hygiene, nutrition and living conditions, and 44% that they are 























Fig. 7. Responsible authorities for prison health-care services
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3.2.2 ADMINISTRATION OF THE BUDGET FOR PRISON HEALTH-CARE SERvICES
The most commonly reported authority responsible for the administration of the prison health-
care budget of the 38 countries that reported data was the Ministry of Justice (42%). Ten countries 
(26%) reported a combination of authorities as responsible, followed by the Ministry of Health or 
other public health authorities (18%), and the health-care department of the prison system (11%). 
Countries reporting other arrangements described these as the Department of Corrective Services, 
Ministry of Home Affairs and Security, prison hospitals, health insurance companies and independent 
prison budgets.
3.2.3 FUNDING SOURCE OF HEALTH SERvICES IN PRISONS
The most common responsible authorities for health-care services funding were the Ministry of 
Justice and the government budget. Twenty-two countries reported a single source of funding, and 
13 reported multiple sources of funding. The most commonly reported sole funding source of health 
services in prisons was the government budget (30%), followed by the Ministry of Justice (22%).
3.2.3.1 Health-care expenses
The obligation of people who are incarcerated to cover health-care expenses is summarized in Fig. 8. 
A minority of countries reported that people who are incarcerated are obliged to pay at least some 
general health-care costs (n = 7) and prescription medication costs (n = 10). Half of the responding 
countries reported that people who are incarcerated are obliged to cover at least some other health-
care expenses (n = 18); a number of countries that provided comments described these other costs 
as being for dental care and prosthetics (n = 5). In addition, countries reported that other additional 
expenses included health care requested by the patient, not the treating doctor, for people with 




























Other expenses (n = 36) General health care (n = 37) Prescription medications (n = 38) 
Fig. 8. Obligation of people who are incarcerated to cover health expenses







Member States are recommended to ensure that all necessary health care for those deprived of their liberty 
is provided to everyone free of charge (15).
3.2.4 AvAILABILITY OF A NATIONAL HEALTH-CARE COMPLAINTS SYSTEM
Most countries (n = 36) reported data on the availability of national health-care complaints systems 
in prisons. Of these, 92% indicated that such systems were available to all people in prison (sentenced 
and unsentenced) (Fig. 9).
 
WHO guidance
A comments and complaints system should be in place for patients to correct apparent faults in the service 
and to learn from the patient’s experience  (15).
3.2.5 LINKS BETWEEN PRISON HEALTH SYSTEMS AND COMMUNITY HEALTH SYSTEMS FOR 
HEALTH CARE
Thirty-three (92%) of 36 countries providing data reported that links existed between prison health care 
and community health-care systems. Descriptions of the links between prison and community health-
care systems varied between countries. For example:
• one country described how formal communication procedures exist to ensure safe and efficient 
continuity of treatment for those requiring treatment for drug dependence, hepatitis C, HIV and 
mental health issues, and that a number of in-reach service providers also work in the community; 
• five countries described links between prison health-care providers and community health care as 
existing only for HIV treatment; and 
• one country reported that linkages between prison health-care service providers and community 
health care rely on the initiative of either prison health staff or health staff working in the community, 
in the case that community health-care providers are aware that a patient is sent to prison.
WHO guidance
A whole-of-government approach for prison health should be implemented, taking account of the need for 





Fig. 9. Availability of national health-care complaints 
system for people in prison (n = 36)
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3.2.6 PRISON STAFF AND HEALTH-CARE STAFF
On average, there are 209.6 prison staff and 31.7 health-care staff per 1000 people in prison. The ratio 
of different categories of health-care staff per 1000 incarcerated people is reported in Fig. 10.
3.2.7 DISCUSSION AND RECOMMENDATIONS
Despite WHO recommendations, the Ministry of Justice was the most common authority across all 
indicators regarding health-care responsibilities. The Ministry of Justice was also most likely to be 
the sole health-care service authority and the sole body responsible for the administration of the 
prison health-care budget. The lack of involvement of the Ministry of Health and other public health 
authorities in essential components of public health governance raises questions about the interface 
between prison health systems and larger public health systems in these countries, and what specific 
arrangements are in place across countries in which the Ministry of Health does not serve this role. 
While a combination of authorities might reflect subnational governance arrangements, more 
information is required to determine the nature of prison health-care governance where more than  
one authority is involved.
Several countries reported costs to people incarcerated for dental care, administrative costs, costs 
for health care on request of the patient, for patients with health insurance and for the purchase of 
vitamins. Concerningly, one country reported that people are required to cover costs in the case  
of self-injury, raising ethical issues, particularly given the elevated risk of self-harm and suicide in  
this population (13). The obligation of people who are incarcerated to cover health expenses for  
general health care, dental care, prescription medications and other expenses in some prison 
























Fig. 10. Ratio of health-care sta	 in prisons per 1000 incarcerated people (2014–2016)






Report recommendations – prison health systems
Recommendation 2. Regardless of which ministry has the authority for prison health care, the responsibility 
for quality assessment of hygiene, health care and organization of health services in custody should sit with 
the ministry responsible for health. Health services must adhere to international human right laws, ensure the 
clinical independence of health-care staff and provide services that are of an equivalent standard to those in 
the community.
Recommendation 3. Member States that do not completely cover all necessary health-care-related 
expenses in prison should extend health-care coverage to all people for all necessary health services to 
ensure that universal health coverage includes people in prison.
Recommendation 4. All Member States should ensure that formal arrangements are in place to enable 
integration of prison health services with the wider public health system to achieve continuity of care for 
individuals released from custody and continuity of universal health coverage for this key population.
3.3 PRISON ENvIRONMENT
Prisons should be treated as a setting for health promotion and incarceration as a time during which 
individuals can address existing health conditions and improve lifestyle factors that may be contributing 
to their NCD burden. The availability of a health-promoting environment, such as smoke-free cells, 
drug-free units and self-cook kitchen areas, is an important component of addressing NCD risk factors. 
A tobacco-free environment encourages individuals to quit smoking tobacco (with appropriate nicotine-
replacement therapy), while drug-free units encourage abstinence from illicit drug use and offer the 
opportunity to seek medical and psychological treatment. Self-cook kitchen areas promote better 
nutrition compared with traditional mass-produced prison meals and also contribute to individual 
autonomy and the development of skills in preparation for release from prison.
3.3.1 SMOKE-FREE CELLS
Of the 32 countries that provided data, 78% reported that smoke-free cells were available in prisons 
(Fig. 11). Of these, 88% of countries reported that they are available in all prisons.
WHO guidance
The WHO Framework Convention on Tobacco Control guidelines on implementing Article 8 states that (40):
careful consideration should be given to workplaces that are also individuals’ homes or dwelling places,  
for example, prisons, mental health institutions or nursing homes. These places also constitute workplaces for 
others, who should be protected from exposure to tobacco smoke.
WHO does not endorse the use of electronic nicotine delivery systems (e-cigarettes and vapes) in the pursuit 
of smoke-free prison environments.
22   
STATUS REPORT ON PRISON HEALTH IN THE WHO EUROPEAN REGION 
3.3.2 PRISON FOOD SYSTEMS
Of the 37 countries with national data available, 97% reported that the production of meals in 
prisons occurs in centralized kitchens. Thirty-eight per cent of countries reported that self-cook 
kitchen areas are available. Two countries reported that meals were not produced in centralized 
kitchens, with other food options or arrangements in place: one articulated that the other 
arrangement was the State providing food for people who are incarcerated, and the other that other 
options included all kinds of food available to people, including fresh and frozen food, dairy products, 
bread and other dry food.
In addition to centralized kitchens, alternative arrangements in place for food systems are shown  























Fig. 12. Alternative food systems available





smoke-free cells (n = 32)
Availability of 
drug-free units (n = 29)
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kitchen areas (n = 37)
Percentage of Member States that responded "Yes"
Fig. 11. Prison environment and NCD risk factors






(n = 4 countries), the existence of stores where people can buy both cooked food and food to 
prepare themselves (n = 3), the availability of a fridge in every cell (n = 1) and systems in place to 
order food (n = 1).
WHO guidance
Prison administrations need to ensure that people in prison have access to a nutritionally adequate and 
balanced diet. The prison environment can contribute to the development of healthy eating patterns when 
appropriate alternative food systems are available. Cookery programmes and the opportunity to cook for 
oneself in prisons should be available (42).
3.3.3 DRUG-FREE UNITS
Twenty-nine countries had national data available and provided a valid response regarding the 
availability of drug-free units in prisons. Among these countries, slightly more than half (55%) reported 
that drug-free units are available in prisons (Fig. 13).
WHO guidance
Drug-free units aim to allow people in prison to keep a distance from the prison drug scene and to provide 
a space to work on dependence-related problems. The focus in these units is on drug-free living. Individuals 
staying in these units sometimes enjoy a regime with more favours and privileges, such as additional leave, 
education or work outside, excursions and more frequent contact with their families. The purpose of staying 
in a drug-free unit is that the individual will remain drug-free or at least become motivated to continue 
treatment after release (15).
Yes, in all prisons 
Yes, in more than
half of prisons











Fig. 13. Availability of drug-free units in prison (n = 39)
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3.3.4 DISCUSSION AND RECOMMENDATIONS
Consistent with the WHO guidance and recent changes in legislation in European prisons regarding 
smoke-free prison policies, most countries reported that smoke-free cells were available in prisons. 
Partial or full smoking bans have been introduced in at least 12 European countries (42), with smoke-free 
prison cells an important step in this process of changing to entirely smoke-free prisons (15). It is not 
possible to determine from the data which Member States have an entirely smoke-free prison estate, 
however, and no conclusions can be drawn from this survey about what supports are in place to 
support smoking abstinence in European prison populations.
Most countries reported that meals are prepared in centralized kitchens. Just 50% of countries reported 
that refrigerators and fresh food are available in prisons, and fewer than half that self-cook kitchens 
(33%) and packaged snacks (47%) are available in prisons. The lack of fresh food and limited food 
options are of concern, given the high prevalence of NCDs in this population. Information about the 
meals produced in centralized kitchens, the role of people in prison in the preparation of their food and 
the dietary choices of people in prison is necessary to gain a more comprehensive understanding of 
the utility of meal production in centralized kitchens and to make an informed assessment about the 
available dietary options in European prisons.
Report recommendations – prison environment
Recommendation 5. Member States should follow the WHO Framework Convention on Tobacco Control by 
giving consideration to the establishment of a smoke-free prison estate and ensure that appropriate support 
is provided to individuals to quit tobacco-smoking, including nicotine replacement therapy and counselling.
Recommendation 6. Fresh and nutritious food options should be provided in place of nutrient-poor 
meals in prisons to prevent NCDs and contribute to promoting healthy lifestyles and establishing a health-
promoting environment.
Recommendation 7. The implementation or expansion of drug-free units in prisons is one mechanism by 
which prisons can become health-promoting environments.
3.4 RISK FACTORS FOR ILL HEALTH
3.4.1 IDENTIFICATION OF RISK FACTORS ON RECEPTION TO PRISON
Few countries were able to provide national data on the indicators of risk factors on reception to 
prison, so given the extent of missing data and the wide variation in prevalence where reported, the 
prevalence range across the available data has been reported (Table 2). A full list of countries that 
provided data contributing to the reported prevalence ranges is available in Annex 4 and a summary of 
the reference groups in Annex 5.
3.4.2 SCREENING FOR MENTAL HEALTH DISORDERS AND SUBSTANCE USE DISORDERS
Screening for mental health disorders and substance use disorders in prison should be made available 
on entry to prison to detect immediate risks, such as suicide risk and alcohol or drug withdrawal. 






The HIPED data show that most Members States currently are conducting assessments for mental 
health disorders and the harmful use of alcohol on reception to prison. Of the 35 countries that 
presented data, 86% reported that screening for severe mental health disorders was available; of 
the 34 countries that provided data on screening for the harmful use of alcohol, 59% reported that it 
was available (Fig. 14). While these screening processes are a step towards an integrated approach to 
NCD management, Member States will need to implement screening tools that capture all NCDs, such 
as cardiovascular disease, respiratory disease, diabetes and cancer, and their associated risk factors 
– tobacco-smoking, harmful alcohol use, nutrition and physical activity – successfully to manage the 
whole spectrum of NCDs.
Table 2. Risk factor prevalence range in prisons in Europe
Risk factor  
(number of Member States that reported data) 
Prevalence range in prisons in 
Europe (percentage) 
Tobacco smoking (n = 5) 60–88.8 
High blood pressure (n = 8) 1.3–9 
Overweight (BMIa > 25) (n = 3) 0.05–4 
Obesity (n = 1) NAb
Current injection drug use (n = 5)c 4.5–25.8 
Ever injection drug use (n = 5)c 0.72–44 
a BMI: body mass index. b NA: not available. c Different Member States provided data on current and ever injecting drug use, so the prevalence ranges do not correspond.




Screening for severe mental
health disorders (n = 35)
Screening for harmful
use of alcohol (n = 34)
Mandatory urine or sputum
testing for illicit substance on
admission to prison (n = 33)
Percentage of Member States in which screening is available
Fig. 14. Availability of screening for mental health disorders and substance use disorders
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WHO guidance
All individuals should undergo health screening on entry to prison to screen for immediate risks for both 
physical and mental health conditions, including suicide, drug or alcohol withdrawal, and medications 
reconciliation. This initial reception screen should prioritize minimizing risks for individuals arriving at prison. 
A second follow-up assessment should be carried out within the first few days in prison to capture complex 
and longer-term conditions (15).
3.4.3 SCREENING FOR SUBSTANCE USE ON RECEPTION TO PRISON
Urine or sputum testing requirements in prisons are presented in Fig. 15. The subgroups for whom 
testing is mandatory included people with histories of drug use, people suspected of drug use and 
people receiving opioid maintenance therapy.
Of the 19 countries reporting that testing is not mandatory, 67% indicated that testing is available 
in prisons, 11% that it is not available, and 22% that other arrangements are in place (which include 
testing being used in some settings to confirm OST, and that it is used under the suspicion of substance 
use). Few countries were able to provide national data on the prevalence of screening for illicit 
substance use and the prevalence of injecting drug use identified on reception to prison. 
The reported prevalence of current injection drug use based on responses from five Member States 
ranged from 5–26%,  while the reported prevalence of lifetime injection drug use, also based on data 











Fig. 15. Urine or sputum testing in prisons (n = 39)







Urine and sputum testing should not be used as a form of control over patients to monitor for illicit drug use 
(15).
3.4.4 SCREENING FOR HARMFUL ALCOHOL USE
Of the 34 countries that provided data on the availability of screening for harmful alcohol use, 59% 
reported that it was implemented in prisons. Screening was implemented in all prisons in 80% of  
these countries.
A validated screening tool was used to screen for harmful alcohol use in 47% of countries that 
provided data.
WHO guidance
The prison setting is an opportunity to detect, intervene or direct into treatment individuals who have 
alcohol problems which may or may not be linked directly to their offences and who are often hard to 
reach (15).
The routine taking of a clinical history can be augmented through the use of a validated alcohol screening 
tool (15).
3.4.5 SCREENING FOR SEvERE MENTAL HEALTH DISORDERS
Of the 35 countries that provided data on screening for severe mental health disorders on admission to 
prison, 86% reported that it was available. Three of the countries reporting that screening was available 
explained that mental health screening is conducted by general practitioners and nursing staff.
3.4.5.1 Diversion to mental health treatment
Of the 29 countries that provided information about the availability of diversion to mental health 
treatment as a result of mental health screening, 84% reported that at least some level of diversion 
to mental health treatment was available. Two countries provided explanations about pathways to 
diversion, specifically that diversion existed as a result of a court decision and psychiatrist's opinion.
WHO guidance
Individuals should be screened for signs of poor mental health and immediate risks on arrival at prison.  
A more detailed assessment should be conducted within the first few days of custody to determine the 
history of mental illness and current mental health status, as well as to screen for traits of personality 
disorder, substance misuse issues, learning disability or difficulty, autistic spectrum disorder, head injury  
and other factors that contribute to vulnerability (such as a long sentence or a violent offence).
Treatment for mental health disorders should include basic interventions, such as psychological support 
through counselling from a psychologist, nurse or stable peer, and psychotropic medications such as 
antipsychotics, as well as motivating patients for treatment and medication during and after prison and 
stabilizing substance misuse problems. It will also be necessary to have a crisis facility within or outside  
the national prison system for a limited number of people in prison with severe psychiatric disorders (15).
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3.4.6 DISCUSSION AND RECOMMENDATIONS
The survey yielded little data on the prevalence of health risk factors on reception to prison. Given the 
high prevalence of NCDs in prison populations (15), the dearth of data in the European Region on NCD 
risk factors is a cause for concern. Complete and comparable information about the risk factors that 
exist is required to address the health needs of people in prison.
The prevalence of current and lifetime injection drug use on admission are fairly consistent with other 
available data, with one recent estimate of the prevalence of lifetime injection drug use in European 
prisons published by the European Monitoring Centre for Drugs and Addiction ranging between 5% 
and 38% (7). Given that only a minority of countries provided data on injection drug use, however, the 
prevalence ranges reported in Table 2 are merely a snapshot of the available countries and are not 
generalizable to the other responding countries or the broader European Region.
While urine tests are a vital part of the initial medical assessment of patients for confirmation of 
opiate use, as presented in Fig. 15, WHO recommends that they not be used as a form of control 
over patients to monitor for illicit drug use (15). Of the 33 countries that provided a response on the 
availability of urine and sputum screening for substance use on admission, 14 (42.4%) reported that 
testing is mandatory for either all people in prisons or certain subgroups. Overall, 31% of countries  
(n = 12) reported that testing is not mandatory but is available, or that other alternatives are in place. 
Two countries (5.2%), however, reported that urine or sputum testing is unavailable. The available 
evidence about referral to treatment is limited.
Given the high prevalence of alcohol use disorders in prison populations (6), appropriate screening 
for alcohol use on admission to prison is an essential component of prison health-care assessment to 
detect, intervene or divert people into treatment.
Many countries indicated that screening for mental health disorders on admission is widely available, 
and that some level of diversion to mental health treatment exists, consistent with previous findings 
from other surveys at European regional level (29). Given that some countries reported mental health 
screening as being unavailable or not available in all prisons, it is apparent that WHO guidelines for 
mental health screening and diversion to mental health are not universally being met across the 
European Region.
Some countries reported that screening was conducted by general practitioners and nursing staff, 
and some also reported diversion as of the result of a court decision and psychiatrist's opinion. There 
nevertheless is no comprehensive evidence across countries about who is conducting screening, what 
tools are used and what the pathways into diversion treatment are.
Report recommendations – screening for NCDs
Recommendation 8. On arrival at prison, all individuals should be screened as soon as practicable (using 
validated screening tools) for immediate risks, including signs of poor mental health, self-harm and suicide, 
substance use disorder and medicines reconciliation.
Recommendation 9. Within the first week of custody, all individuals should undergo a thorough health 
assessment to screen for all physical and mental health needs. Individuals requiring treatment should be 
referred to appropriate health-care services.






Report recommendations – screening for NCDs contd
Recommendation 10. Member States should implement validated screening tools that capture information 
on NCDs, including cardiovascular disease, respiratory disease, diabetes and cancer, and their associated risk 
factors – tobacco-smoking, harmful alcohol use, nutrition and physical activity.
Recommendation 11. Data from health screening in prison should be captured and reported at national 
level to monitor: prevalence rates of diseases and risk factors; changes in health status; improvements in 
health outcomes in the prison population; and prison health systems’ progress in addressing the health 
needs of the population.
3.5 DISEASE SCREENING ON ADMISSION
3.5.1 SCREENING FOR ORAL HEALTH
Of the 35 countries indicating that information on oral health screening was available, 66% reported 
that screening for oral health problems was available on reception (Fig. 16).
WHO guidance
Oral health should be included in induction programmes and health triage systems in prisons (15).
A comprehensive dental health-care service should be in place to provide an appropriate range of 
treatments based on patients’ clinical needs (15).
3.5.2 SCREENING FOR COMMUNICABLE DISEASES
Thirty-five Member States provided data on screening for HIV, 86% of which reported that HIV testing is 
available but not mandatory. Of the 36 Member States that provided data on screening for hepatitis B, 
83% reported testing is available but not mandatory. Eighty-three per cent of the 35 Member States that 
provided data on screening for hepatitis C reported that testing is available but not mandatory. Of the 34 
Member States that provided data on screening for STIs, 73% reported that screening for STIs is available 






Fig. 16. Availability of oral health screening on
reception to prison (n = 35)
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WHO guidance
Pre- and post-test counselling for BBV screening should be available in prisons (15).
3.5.3 PREvALENCE OF COMMUNICABLE DISEASES
Table 3 shows the prevalence of communicable diseases in prisons in Europe.
3.5.4 STIs
Thirty-four countries had national data on the availability of STI screening, 73% of which reported 
that screening for STIs was available. Fewer countries provided data on the prevalence of syphilis and 
chlamydia in males and females on reception. The prevalence ranges across the countries providing 
data are reported in Table 3.
WHO guidance
Voluntary screening for STIs such as chlamydia, gonorrhoea and syphilis should be available to people in 
prison (15).
3.5.5 HIv
Thirty-eight countries provided information about the availability of HIV testing on reception to prison. 
Three (8%) reported that no national data were available. Of the remaining 35 countries that indicated 
national data were available and provided a response, 11% reported that testing is mandatory for all 
people who are incarcerated, one country that it is mandatory for certain subgroups, and 86% that 
testing is not mandatory. Of the 30 countries in which HIV testing is not mandatory, 47% reported that 
HIV testing is available and 53% that it is offered routinely to all people who are incarcerated on an 
opt-out basis.
Data for the percentage of HIV screening and prevalence of HIV on reception are available in Table 3.
Screening for sexually
transmitted infections is
available on entry to prison
(n = 34)
Hepatitis C testing is
available, but not mandatory,
on entry to prison (n = 35)
Hepatitis B testing is
available, but not mandatory,
on entry to prison (n = 36)
HIV testing is
available, but not mandatory,
on entry to prison (n = 35)
Percentage of Member States in which screening is available





Fig. 17. Screening for communicable diseases







Member States should encourage use of the United Nations comprehensive package of services to address 
HIV and viral hepatitis B and C. Prison systems must ensure all people in prison have easy access to client-
initiated testing and counselling programmes on request and at any time during their imprisonment, and 
testing should never be mandatory. (26).
3.5.6 HEPATITIS B
Thirty-six countries indicated that national data were available and provided a valid response, 83% of 
which reported that testing is not mandatory. Of the 30 countries in which hepatitis B testing is not 
mandatory, 52% reported that hepatitis B testing was available, 38% that it was offered routinely to 
people who are incarcerated on an opt-out basis, one  that testing was not available, two that other 
arrangements were in place, and data was missing for one country. Of the two countries with other 
hepatitis B testing arrangements, one reported that it is offered by a nongovernmental organization 
(NGO) and the other that testing is conducted only on the basis of clinical suspicion.
The prevalence of positive tests for hepatitis B is summarized in Table 3.
WHO guidance
All people in prison, and prison staff, should be vaccinated against hepatitis B. Any individual entering 
prisons who has not been vaccinated should be offered the hepatitis B vaccination (15).
Table 3. Prevalence of communicable diseases in prisons in Europe
 
Communicable disease 
Prevalence in prisons in Europe 
(number of Member States that reported data) 
HIv Males: 0.03–5.4% (n = 11)a
Females: 0–4.7% (n = 9)b 
Hepatitis Bc Percentage positive HBsAgd: 0–30% (n = 8)
Percentage positive Anti-HBe: 0–25% (n = 6) 
Hepatitis C Percentage positive Anti-HCVf: 8.1–91% (n = 11)g
Percentage positive HCV RNAh: 5.2–82% (n = 8)i
Chlamydiaj Males: 0–24% (n = 6)
Females: 0–30.7% (n = 5)
Syphilisj Males: 0–1.8% (n = 10)
Females: 0–0.76% (n = 12) 
TBk Cases detected of new/relapse TB: 0–25% (n = 10)
a Reported year range 2012–2017. b Reported year range 2014–2017. c Data were provided for the most recent year available. The reported year was either missing or 
 ranged between 2015 and  2017. d HBsAg: hepatitis B virus surface antigen. e Anti-HB: hepatitis B virus surface antibody. f Anti-HCV: hepatitis C virus antibody test.
g The reported years were 2006, 2015 and 2016. h HCV RNA: a test to measure the level of the hepatitis C virus in the bloodstream. i The reported years ranged between 
 2015 and 2017. j Reported years were either missing, 2006, 2015 or 2016, or 2015–2017. k Reported year was either missing, 2010 or 2014–2016.
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3.5.7 HEPATITIS C
Thirty-five countries indicated that national data were available, 83% of which reported that testing is 
not mandatory.
Of these countries, 48% reported that hepatitis C testing was available, 41% that it was offered 
routinely to people who are incarcerated on an opt-out basis, one that testing was not available, and 
two that other arrangements were in place (one country reported that it is offered by a NGO and the 
other that testing is conducted only on the basis of clinical suspicion).
The prevalence of positive tests for hepatitis C is summarized in Table 3.
WHO guidance
There is currently no vaccine to prevent hepatitis C infection, so it is essential to screen for the 
hepatitis C virus on entry to prison and to prevent transmission within prison (15).
3.5.8 TB
The prevalence of testing and detection of new or relapse TB is summarized in Table 3.
The range of people tested for TB varied from 0–100%: this might indicate that testing is unavailable 
in some countries and mandatory in others, or that it may be affected by variations in the reference 
population, but there is insufficient information from which to draw conclusions.
WHO guidance
TB infection control is a combination of measures aimed at minimizing the risk of TB transmission. 
The basis of such infection control is early and rapid identification of individuals with suspected and 
known TB and effective treatment of disease (15).
3.5.9 DISCUSSION AND RECOMMENDATIONS
WHO recommends that prisons should offer a comprehensive dental health-care service and provide an 
appropriate range of treatments based on patients’ clinical needs. Oral health should also be included 
in prison induction programmes and health triage systems (43). While the available data suggest that 
oral health screening is available in 66% of prison health administrations and that oral health screening 
is available in all prisons in 76% of these administrations, it appears not to be universal in European 
prison administrations. Conclusions about the provision and accessibility of prison dental health services 
cannot be drawn from the data, but a number of countries that reported the obligation of people in 
prison to cover other health-care costs (other than general health care or prescription medications) 
described these costs as being for general dental care and more complex components of dental care, 
including prosthetics, raising questions about the accessibility of these services in European prison 
health services.
Consistent with WHO recommendations for non-mandatory HIV and hepatitis testing, the majority 
of countries reported that non-mandatory testing was available on reception for HIV, hepatitis B 
and hepatitis C. A minority of countries, however, reported mandatory HIV or hepatitis testing for all 
incarcerated people, or certain subgroups. These practices do not align with WHO's position on non-






mandatory testing based on the ethical principles of informed consent. One country does not offer any 
testing for hepatitis B or C, which could contribute to an increased risk of transmitting these infections 
among other people incarcerated in the prison system and worsening of chronic conditions associated 
with viral hepatitis.
WHO recommends voluntary screening for other STIs, including chlamydia, gonorrhoea and syphilis, 
should be offered to all people in prison who exhibit high-risk health behaviours (15). Approximately 
three quarters (73%) of countries that provided a response about the availability of STI screening in 
prisons reported that it was available in some or all prisons.
Given that people in prison are at higher risk of these infections, the lack of universal STI screening 
across the European Region has implications for health outcomes in this population.
Conclusions about the availability and implementation of pre- and post-test counselling, which are 
considered important components of screening (15), cannot be drawn from the available data.
WHO recommends that people should not enter prisons until it has been confirmed that they do 
not have infectious TB, and that systematic passive and active case-finding should be carried out 
simultaneously (15). WHO strongly recommends that GeneXpert MTB/RIF should be used as the initial 
diagnostic test in individuals suspected of having multidrug-resistant or HIV-associated TB (15). The 
percentages of people being tested for new/relapse TB and people who have TB being tested for HIV 
both range from 0–100%. This appears to indicate that testing might be unavailable in some countries, 
or that all people are tested for TB and TB/HIV in some countries, consistent with WHO guidelines. 
This information alone is insufficient to draw any conclusions about the testing practices used by the 
responding countries, including whether active or passive case-finding is implemented.
Report recommendations – disease screening
Recommendation 12. Member States that currently do not screen for oral health issues on reception to 
prison should ensure that dental health-care services are available for assessment and treatment of oral 
health issues both on entry to prison and throughout imprisonment.
Recommendation 13. Member States should ensure that: testing is available, but not mandatory, for 
HIV, hepatitis B, hepatitis C and STIs on entry to prison; pre- and post-test counselling is available; and 
appropriate treatment or vaccination is available in prison.
Recommendation 14. Testing for TB on reception to prison should be implemented in all Member States 
and treatment commenced for individuals testing positive to minimize the risk of transmission of TB within 
prisons.
3.6 PREvENTION OF INFECTION
The availability of resources for prevention of infection (lubricants, condoms, disinfectants, and needle 
and syringe exchange programmes) is presented in Fig. 18.
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Of the 36 countries that provided data, 80% reported that condoms are available in prisons. Sixty-nine 
per cent of the 35 countries that provided data reported that a full vaccination course against hepatitis B 
is available, 47% of the 30 countries that provided data reported that lubricants are available, and 45% 
of the 33 countries that provided data reported that disinfectants are available.
A minority of countries (17%) indicated that needle and syringe exchange programmes were available 
in at least some prisons. A number of countries provided explanations for the lack of needle/syringe 
exchange programmes, including that it was simply not deemed necessary (n = 1), drug use is 
prohibited (n = 1) and that two pilot implementations conducted in 2009 were considered ineffective 
(that is, no needles or syringes were exchanged).
Of the 15 countries in which disinfectants were available, 87% reported that they are available free 
of charge. Eighty-six per cent of the 29 countries in which condoms are available in prisons reported 
that they are available free of charge. Of the 14 countries that reported that lubricants are available in 
prisons, 86% reported that they are available free of charge.
WHO guidance
Easily, discreetly and freely available condoms and lubricants should be available in prisons (15).
Needle and syringe exchange programmes are one example of harm-reduction interventions that can be 
introduced to minimize the risk of transmission between people who inject drugs (15).
The provision of bleach or other disinfectants to people who are incarcerated should be considered as an 
option to reduce the risk of transmission of BBVs through the sharing of injection equipment, particularly 
when sterile injection equipment is not available (15).
3.6.1 NON-SUPERvISED FAMILY AND PARTNER vISITS
Thirty-seven countries indicated that data were available, 81% of which reported that non-supervised 
family/partner visits are available in prisons. Of these countries, 53% reported that non-supervised 
visits are available in all prisons, 37% that they are available in more than half of prisons, and 10% that 
they are available in fewer than half of prisons.
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Fig. 18. Availability of prevention measures for communicable diseases 







To create the best conditions for good health and effective health care, prisons should adopt a 
whole-prison approach to the provision of opportunities to maintain family links through visits (15).
3.6.2 HEPATITIS B PREvENTION
Among the 35 countries with national data available and which provided a valid response, 67% 
reported that a full vaccination course against hepatitis B is available in prisons, while 31% reported 
that a full vaccination course is not available. Data for the 24 countries that indicated a full vaccination 
course is available are summarized in Fig. 19. Of the five countries that reported other arrangements 
were in place for hepatitis B vaccinations, one offers the vaccination course to men who have sex with 
men, and another reported that it was available to a number of groups, including anyone who asks for 
the vaccine, people who use drugs, people from high-endemic regions, sex workers, people who are 
incarcerated and staff who face professional risks.
Two countries provided data for the percentage of incarcerated people who are fully vaccinated for 
hepatitis B (66% and 68.8%).
WHO guidance
All people entering prison who are not know to be immune to hepatitis B due to a full vaccination 
course or previous infection should be offered the vaccine for hepatitis B on admission (15).
































Fig. 19. Availability of a full vaccination course against hepatitis B in prisons (n = 24)a
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3.6.3 DISCUSSION AND RECOMMENDATIONS
Overall, harm-reduction strategies and resources for the prevention of STIs appear to be implemented 
or distributed rarely in European prisons. Where available, the information about how these strategies 
are implemented and how resources are distributed is limited, including whether the approaches 
are acceptable and anonymous. More information is needed about these strategies and resources, 
including information about barriers to implementation for countries, perceived need and perspectives.
WHO recommendations for the prevention of STIs include easily, discreetly and freely available condoms 
and lubricants, and rooms for conjugal visits with these resources available (15). While the results of this 
survey indicate that condoms are available in most countries (74%), they were unavailable in the prison 
administrations of seven countries (18%), similar to findings of a previous national survey of 27 European 
countries in which condoms were unavailable in nine (33%) (32). While the majority of countries that 
reported condoms were available also reported that they are free of charge (n = 25), several reported 
that condoms were available to people in prison only at a cost (n = 4), raising questions about the 
accessibility of these products. Additionally, fewer than half of countries (n = 14) reported that lubricants 
were available in prisons  and two indicated they were available only at a cost, which indicates that most 
countries are not meeting WHO's guidelines for prevention.
WHO recommends a harm-reduction approach to injection drug use through the provision of injection 
kits to minimize the risk of transmission between people who inject drugs. The provision of health-
promotion information, bleach and needles to people in prison is recommended to minimize the risk  
of unsafe tattooing and piercing equipment (15). Implementation of these recommendations was rare:  
a minority of countries indicated that needle and syringe exchange programmes were available in 
prisons (n = 6, 15.4%) and even fewer reported that the programmes existed in all prisons (n = 2, 5.1%). 
More information is required about implementation efforts, barriers and perceived need of countries 
regarding these initiatives.
WHO recommends that all people entering prison who have not been vaccinated against hepatitis B 
should be offered the vaccine on admission, but few countries (n = 11) reported that a full vaccination 
course against hepatitis B was offered to all eligible incarcerated people on admission, or provided data 
on the prevalence of people vaccinated for hepatitis B.
Report recommendations – prevention of infection
Recommendation 15. All countries should ensure that evidence-based infection control measures, such 
as condoms, lubricants and disinfectants, are easily and discreetly available in prisons to help prevent the 
transmission of infections.
Recommendation 16. The implementation of needle and syringe exchange programmes in prisons should 
be considered by all Member States as an example of a harm-reduction intervention to minimize the risk of 
transmission of infections, in line with community practice to ensure equivalence of care.
Recommendation 17. Member States should ensure that the full vaccination course for hepatitis B is offered 
to all individuals entering prison not know to be immune to hepatitis B due to a full vaccination course or 
previous infection.







3.7.1 TREATMENT, INTERvENTIONS AND GUIDELINES FOR NCDs
Of the 36 countries that provided data on treatment for mental health and substance use disorders, 
97% reported that specialist mental health support is available, while 81% of 35 responding countries 
reported that OST is available for both sentenced and pre-trial individuals. Sixty-two per cent of the 
37 countries that provided a response reported that national guidelines for the treatment of severe 
mental health disorders in prisons exist, and 51% of the 35 countries that reported on the existence of 
national guidelines for the prevention of post-release drug-related deaths reported that such guidance 
existed (Fig. 20).
3.7.2 TREATMENT OF SUBSTANCE USE DISORDERS
Data about available treatment for substance use disorders in prisons are presented in Fig. 21. 
Examples of other treatments for drug dependence reported by six countries included music therapy 
programmes (n = 1), rehabilitation programmes (n = 1) and eye movement desensitization and 
reprocessing in some prisons (n = 1).
Thirty-two (89%) of the 36 countries provided data on OST, 89% of which indicated that it is available 
in prison. Among these countries, 81% reported that substitution treatment is available for people who 
either are sentenced or in pre-trial detention, while 19% reported that it is only available for people 
who are sentenced.
Among the 35 countries with national data and which provided a valid response, 51% reported the 
existence of national guidelines for the prevention of drug-related death after release.
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Fig. 20. Availability of treatment, interventions and guidelines for mental health disorders
and substance use disorders 
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WHO guidance
OST and drug counselling are among recommended methods of substance use treatment (15).
People who are incarcerated should not be released without adequate medication and appropriate 
arrangements for follow-up in the community (15).
3.7.3 MENTAL HEALTH TREATMENT
Thirty-six countries reported on the accessibility of mental health support delivered by specialist health 
staff in prisons (including peer support workers, Samaritans, counselling support or psychological 
treatment), with 97% reporting that access to such mental health support was available in prisons.
Among the 37 countries providing a valid response, 62% reported that national guidelines for the 
treatment of severe mental health disorders in prison existed.
WHO guidance
Mental health treatment for individuals with mental illness and mental health promotion for all 
people in prison are crucial parts of health care in prisons (15).
3.7.4 DISCUSSION AND RECOMMENDATIONS
The majority of countries reported that access to mental health support delivered by specialist health 
staff in prisons (including peer support workers, Samaritans, counselling support or psychological 
treatment) existed in prison health systems, but a number reported that this was not implemented 
universally, despite WHO recommendations. Twenty-three countries reported the existence of national 











































Fig. 21. Available treatments for substance use disorder






guidelines for the prevention of drug-related death existed, which has important implications for how 
mental health and substance use treatment is operationalized in prisons.
All countries that provided data on the available treatments for drug dependence indicated that some 
sort of treatment was available. WHO has stated that drug-free units, OST and drug counselling are 
among the recommended methods of substance use treatment (15). The results of this survey indicate 
that OST is available in most countries (n = 32), but it was reported as unavailable in four. Given the 
importance of OST in reducing morbidity and mortality in this population, its lack in these prison 
administrations is a cause for concern. Previous findings indicate that access to, and coverage of, OST in 
prisons is higher in countries with a long history of such provision (32), but few conclusions can be drawn 
using the results of the HIPED survey.
Report recommendations − treatment for mental health and substance use disorders
Recommendation 18. Member States that currently do not offer OST for both sentenced and pre-trial 
individuals should implement programmes in line with WHO guidance.
Recommendation 19. National guidelines for the treatment of severe mental health disorders in prisons 
should be developed, implemented and monitored by all Member States to ensure equivalence of care 
for those with mental health disorders in prison. This should include access to specialized mental health 
treatment for people with a mental health disorder and mental health promotion for all within prison.
Recommendation 20. All Member States should develop and implement national guidelines for the 
prevention of post-release drug-related deaths, including the provision of appropriate medication on release 
from prison and arrangements for continuity of care with community health services. 
3.8 MORTALITY
The overall mortality rate in custody and the mortality rates for each subgroup per 10 000 person years 
in custody are presented in Fig. 22.
In total, 14% of deaths were from suicide (n = 13), and the suicide rate was 6.5 per 10 000 incarcerated 
people (n = 14).
The overall mortality rate calculated for all participating countries was substantially higher (45 per  
10 000 individuals) than the median mortality rate reported in a Council of Europe survey (27 per 10 000 
individuals) (4). The proportion of deaths by suicide reported by responding countries, however, was 
10% lower than that reported for European prisons in 2014 (4). Consistent with what is known from the 
literature (12), the mortality rate for men was higher than that for women. Conclusions about other causes 
of death, which has important implications for prevention and health-service planning to reduce the 
elevated risk of mortality following release, cannot be drawn from this survey.
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WHO guidance
All staff working in prisons should have a basic level of knowledge and understanding of health 




























Fig. 22. Mortality rates per 10 000 incarcerated person years (2014–2016)
4. 
LIMITATIONS
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Most countries indicated that there were no national data available for many indicators or did not 
provide a valid response (data were missing). Only one country was able to provide a valid response 
for one particular indicator. The incompleteness of this dataset hinders the interpretation and 
generalizability of the data for the entire European Region. It should also be noted that responses are 
not necessarily indicative of practice in all instances, and that the survey did not collect data on the 
extent of coverage of prison health services within a country; responses therefore may not reflect the 
entire spectrum of practice within a country’s prison health system.
A number of countries found that some HIPED indicators and question formats were inconsistent 
with their data-collection processes and systems. In addition, some countries faced challenges with 
subnational governance arrangements, which is a consideration for future iterations of this survey.
Little is known about the data-collection practices of countries in the European Region, including 
variations in data collection and barriers to collecting data. This information is important to inform 
future data-collection efforts of this kind.
While the survey provided a broad summary of health systems and services, there were some 
limitations. More detailed and nuanced data about governance, prevention of illness, harm reduction, 
prevalence of other conditions overrepresented in this population, screening practices and pathways 
into treatment for communicable and noncommunicable disease are necessary to draw more concrete 
conclusions from the data and facilitate more meaningful comparisons between countries.
More information about continuity of care practices and policies, including post-release transitional 
support planning for health, is of great importance for comparing prison health systems across the 
European Region. Such data would assist in addressing key issues associated with the dovetailing of 
prison health systems and national health systems, ensuring adequate access to quality health care for 
people who experience incarceration, and promoting continuity and quality of care.
Another key limitation is the lack of data collected about young people in the criminal justice system, 
beyond the population extent and number of deaths. Given that data available about the number of 
young people in detention, let alone the health services that exist in detention, are limited, the survey 
findings make an important contribution. More information about the health status of young people 
in detention and the health systems and services that exist to serve them nevertheless is essential. 
Similarly, no data were collected about specific programmes and services for women and older people, 
who have unique health needs both in prison and after release. Collecting this information is essential 
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HIPED is one of the first regional data-collection efforts that aims to amass comprehensive, comparable 
data on prison health systems in the European Region across eight key domains of prison health-care 
governance, systems and health-care services.
In summary, the findings suggest that some WHO recommendations are being met by a considerable 
number of countries across the Region. Most of the responding countries reported implementing WHO 
guidelines on mental health screening, substance use treatment and non-mandatory screening for 
BBVs and STIs.
For a number of indicators, however, countries reported practices that were not in line with WHO 
recommendations. For example, a number reported that key screening processes or treatments were 
unavailable, or that mandatory screening practices were in place for BBVs and STIs, which raises ethical 
questions and concerns about health equity in European prison health-care systems. Additionally, few 
countries reported the availability of important harm-reduction strategies, such as needle and syringe 
exchange programmes and the provision of disinfectants.
Incomplete responses to some indicators suggests that important and essential data on the health 
status of people in prison are not be being collected by some countries. The WHO Lisbon conclusions 
state that health services must be evidence-based and should consider the transition of individuals from 
custody to community, requiring cross-sectoral collaboration and a systems leadership approach to 
health. Good-quality data on the health of prison populations are essential, as they provide an evidence 
base for developing and implementing effective policies. The availability of data on people in prison 
and prison health-care systems allows countries to assess their progress on achieving universal health 
care, address entrenched health inequities and “leave no one behind” in pursuit of the SDGs.
A further limitation of the HIPED data is that currently they are not harmonized with other information 
sources across European and international organizations. Future iterations of the HIPED could address 
this by harmonizing indicators through working with other data-collecting agencies.
Despite the limitations of the HIPED data, this database sheds light on what is known and unknown 
about the health status of people in European prisons and the health services that exist to meet 
their health needs. The findings of HIPED confirm the complexity of health problems experienced by 
people in prison and reaffirm the need for Member States to invest in quality health care for people 
experiencing incarceration. In addition, the collection of these data is an important prerequisite for 
developing evidence-based policy around prison health systems and services in the European Region. 
Improving prison health services depends on effective collection and use of information to inform policy 
and investment, and to enable evaluation of services and interventions. The data collated by the HIPED 
represent a promising step for developing future work to collect data on prison health systems and 
services both in the European Region and internationally.
 
6. 
KEY MESSAGES AND 
RECOMMENDATIONS
  6.1 Report key messages
  6.2 Report recommendations
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This first iteration of the HIPED is a major step toward understanding the health needs of those in 
prison and the structure of health-care systems in prisons across Europe. There is a real need, however, 
for improved data-collection systems in Member States to ensure that the whole picture of health in 
prisons is captured. 
Many HIPED indicators lack responses from most Member States (for example, obesity prevalence was 
reported by only one country), so it is impossible to know the prevalence within the prison population, 
let alone compare prevalence to that in the community. WHO is committed to “leaving no one behind” 
in the pursuit of the SDGs and universal health coverage, but the incomplete responses for many HIPED 
indicators across Member States indicates that people in prison are still being left behind.
Until the health status of people in prison is completely understood, it will be challenging to show how 
health-care services in prisons are contributing to improved health and well-being for this vulnerable 
population. Member States need good-quality data to inform the development and implementation of 
evidence-based public health policies for prison health systems.
6.1 REPORT KEY MESSAGES
This report highlights a number of areas in which Member States, on the whole, are not complying with 
WHO guidance on health in prisons. Recommendations to remedy the situation are listed at the end of 
each section and are collated below in section 6.2.
The report also yields some key messages about the state of prison health in Europe and provides 
general recommendations that will help to ensure Member States can continue to monitor and improve 
prison health systems.
The first key message is that collection of national health data on individuals and prison populations is 
lacking. This is evident in the incomplete data for many of the HIPED indicators and represents a failure 
to understand the basic health needs of the prison population. Without these data, it is impossible to 
know whether health services in prisons are having a positive effect on the health of people in prison 
and addressing the significant health inequalities this vulnerable population faces. To achieve universal 
health care as part of the SDGs, the prison population must not be forgotten or left behind, and prison 
health must be seen as part of broader public health policies. It therefore is vital that Member States 
are able to monitor the health status of those in prison through comprehensive data-collection systems. 
Only then will the WHO HIPED be able effectively to compare health in prisons across Europe and 
contribute to policy decisions for prison health in the Region.
WHO recommends that Member States:
• develop surveillance and reporting systems for the health of people in prison, supported by WHO 
and other relevant stakeholders;
• ensure the availability of screening, treatment and mechanisms for the prevention of illness in 
all prison and youth detention settings across their administrations, respecting the rights and 
autonomy of people who are incarcerated, as articulated by WHO guidelines (15,44);
• use valid approaches to screening and assessment, and evidence-based approaches to treatment 
and implementation of harm-reduction programmes; and














• support high-quality, independent research on the health of people who are incarcerated and on the 
impact of incarceration on health, including:
• prospective studies to examine health outcomes after release from prison and youth detention 
 (including the use of linked administrative data where feasible);
• rigorous evaluation of health-focused interventions;
• evaluation of diversion and alternatives to incarceration; and
• economic evaluation of outcomes from a whole-of-government perspective.
The second key message is to emphasize the importance of creating a health-promoting environment 
in prisons in which individuals receive high-quality health care that is of an equivalent standard to that 
in the community, regardless of which ministry has the authority for health care in prisons. Prison is a 
setting in which health promotion can take place, so prisons need to be health-enabling environments 
that can contribute to an improvement in health and well-being. Prisons provide an opportunity to 
change lifestyles, and time spent in custody can be used to improve existing health conditions through 
appropriate treatments and modify health-risk behaviour for NCDs through, for example, cessation of 
tobacco-smoking and improved nutrition and physical activity.
There are many different models of prison health-system governance in the European Region, and most 
survey respondents reported that the responsibility for prison health services lies with the Ministry 
of Justice, rather than the Ministry of Health. It is essential that prison health is viewed as part of the 
broader public health agenda and that prison health policy is recognized and incorporated into general 
public health policy. Intersectoral working is essential to ensure close collaboration among ministries 
to promote improvements in prison health systems. By ensuring that the human rights of people in 
prisons are upheld, that health-care services are provided by clinically independent practitioners, and 
that individuals receive continuity of care on release from prison, Member States can contribute to 
“leaving no one behind” as part of the SDGs.
 WHO recommends that Member States:
• recognize prisons and youth detention centres as health-care delivery sites of critical importance for 
identifying health needs at individual level and addressing health inequalities at population level;
• ensure that prisons and youth detention settings are included in all public health strategies, policies 
and planning by adopting the approach of prison health in all policies;
• implement an evidence-informed approach to decision-making about health systems and services 
in prison and youth detention settings, including with respect to coordination and continuity of care 
between prison/detention and community;
• recognize that effective, sustainable responses to the health needs of people who experience 
incarceration are contingent on continuity of care, which in turn requires close coordination of prison 
and community health services;
• prioritize continuity of care and effective flow of health information between prison/detention and 
community health services; and
• ensure that prisons, pre-trial detention centres and youth detention centres are included in national 
data collections and other routine monitoring regarding population health, health systems and 
services.
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6.2 REPORT RECOMMENDATIONS
Report recommendations 
Recommendation 1. Member States should ensure that data are collected on the number of people 
entering and leaving prison, and demographics of people in prison. Health services in prisons must reflect the 
specific health needs of the population, based on formal health needs assessments.
Recommendation 2. Regardless of which ministry has the authority for prison health care, the responsibility 
for quality assessment of hygiene, health care and organization of health services in custody should sit with 
the ministry responsible for health. Health services must adhere to international human right laws, ensure the 
clinical independence of health-care staff and provide services that are of an equivalent standard to those in 
the community.
Recommendation 3. Member States that do not completely cover all necessary health-care-related 
expenses in prison should extend health-care coverage to all people for all necessary health services to 
ensure that universal health coverage includes people in prison.
Recommendation 4. All Member States should ensure that formal arrangements are in place to enable 
integration of prison health services with the wider public health system to achieve continuity of care for 
individuals released from custody and continuity of universal health coverage for this key population.
Recommendation 5. Member States should follow the WHO Framework Convention on Tobacco Control by 
giving consideration to the establishment of a smoke-free prison estate and ensure that appropriate support 
is provided to individuals to quit tobacco-smoking, including nicotine replacement therapy and counselling.
Recommendation 6. Fresh and nutritious food options should be provided in place of nutrient-poor 
meals in prisons to prevent NCDs and contribute to promoting healthy lifestyles and  establishing a health-
promoting environment.
Recommendation 7. The implementation or expansion of drug-free units in prisons is one mechanism by 
which prisons can become health-promoting environments.
Recommendation 8. On arrival at prison, all individuals should be screened as soon as practicable (using 
validated screening tools and protocols) for immediate risks, including signs of poor mental health, self-harm 
and suicide, substance use disorders and medicines reconciliation.
Recommendation 9. Within the first week of custody, all individuals should undergo a thorough health 
assessment to screen for all physical and mental health needs. Individuals requiring treatment should be 
referred to appropriate health-care services.
Recommendation 10. Member States should implement validated screening tools that capture information 
on NCDs, including cardiovascular disease, respiratory disease, diabetes and cancer, and their associated risk 
factors – tobacco-smoking, harmful alcohol use, nutrition and physical activity.
Recommendation 11. Data from health screening in prison should be captured and reported at national 
level to monitor: prevalence rates of diseases and risk factors; changes in health status; improvements in 
health outcomes in the prison population; and prison health systems’ progress in addressing the health 
needs of the population.
Recommendation 12. Member States that currently do not screen for oral health issues on reception to 
prison should ensure that dental health-care services are available for assessment and treatment of oral 
health issues both on entry to prison and throughout imprisonment.














Report recommendations contd 
Recommendation 13. Member States should ensure that: testing is available, but not mandatory, for 
HIV, hepatitis B, hepatitis C and STIs on entry to prison; pre- and post-test counselling is available; and 
appropriate treatment or vaccination is available in prison. 
Recommendation 14. Testing for TB on reception to prison should be implemented in all Member States 
and treatment commenced for individuals testing positive to minimize the risk of transmission of TB within 
prisons.
Recommendation 15. All countries should ensure that evidence-based infection control measures, such 
as condoms, lubricants and disinfectants, are easily and discreetly available in prisons to help prevent the 
transmission of infections. 
Recommendation 16. The implementation of needle and syringe exchange programmes in prisons should 
be considered by all Member States as an example of a harm-reduction intervention to minimize the risk of 
transmission of infections, in line with community practice to ensure equivalence of care. 
Recommendation 17. Member States should ensure that the full vaccination course for hepatitis B is offered 
to all individuals entering prison not know to be immune to hepatitis B due to a full vaccination course or 
previous infection.
Recommendation 18. Member States that currently do not offer OST and counselling for both sentenced 
and pre-trial individuals should implement programmes in line with WHO guidance.
Recommendation 19. National guidelines for the treatment of severe mental health disorders in prisons 
should be developed, implemented and monitored by all Member States to ensure equivalence of care 
for those with mental health disorders in prison. This should include access to specialized mental health 
treatment for people with a mental health disorder and mental health promotion for all within prison.
Recommendation 20. All Member States should develop and implement national guidelines for the 
prevention of post-release drug-related deaths, including the provision of appropriate medication on release 
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ANNEX 1. HEALTH IN PRISONS EUROPEAN DATABASE (HIPED) INDICATORS
SECTION 1 – PRISON POPULATION STATISTICS    
Indicator name in database Specification for metadata
Capacity Total capacity of prisoners. Data as of 1 January (unless otherwise 
specified)
Total number of prisoners Total number of prisoners. Data as of 1 January (unless otherwise 
specified)
Number of unsentenced/remand prisoners Number of unsentenced/remand prisoners, excluding those in police 
custody. Data as of 1 January (unless otherwise specified)
Number of female prisoners Number of female prisoners. Data as of 1 January (unless otherwise 
specified)
Number of underage prisoners Number of prisoners under 18 years of age. Data as of 1 January (unless 
otherwise specified)
Number of prisoners over 55 years Number of prisoners over 55 years of age. Data as of 1 January (unless 
otherwise specified)
Number of ethnic/racial minority prisoners Number of prisoners from ethnic/racial minority groups. Data as of  
1 January (unless otherwise specified)
SECTION 2 – PRISON HEALTH-CARE SYSTEM
Grouping Indicator name in database Specification for metadata
Prison health-care 
oversight
Prison health-care authority Agency/agencies with authority of prison health-care services
Prison health-care budget 
administration Agency/agencies administrating the prison health-care budget
Prison health-care funding 
source Funding source of health services utilized by prisoners
Obligation for 
prisoner coverage  
of expenses
General health services Prisoners in the country are obliged to cover costs for general health 
services
Prescription medication Prisoners in the country are obliged to cover costs for prescription 
medication
Other expenses Funding source of health services utilized by prisoners
Responsibilities of 
Ministry of Health or 
other public health 
authority
Authorization of prison health 
services
Ministry of Health or other public health authority responsible for direct 
or indirect authorization of prison health services
Assessment of prison health 
services
Ministry of Health or other public health authority responsible for 
assessment of prison health services
Inspection of prison hygiene, 
nutrition and living conditions
Ministry of Health or other public health authority responsible for 
inspection of prison hygiene, nutrition and living conditions
Medical document inspections Ministry of Health or other public health authority responsible for 
inspection of medical documentation in prisons
Prevention of infectious 
diseases
Ministry of Health or a public health authority responsible for prevention 
of infectious diseases in prisons
National health-care 
complaint system
National health-care  
complaint system Existence of national health-care complaint system available to prisoners
Number of 
complaints Number of complaints Number of health-care complaints received from prisoners


















SECTION 2 – PRISON HEALTH-CARE SYSTEM contd
Grouping Indicator name in database Specification for metadata
Number of staff
Number of prison staff Total number of prison staff working in prisons on the basis of full-time 
equivalents (including external service providers)
Number of health-care staff
Total number of health-care staff (physicians, nurses, nursing assistants, 
etc., including external service providers) working in prisons on the basis of 
full-time equivalents
Number of physicians Total number of physicians (MDs, including external service providers) on 
the basis of full-time equivalents
Number of psychiatrists Total number of psychiatrists on the basis of full-time equivalents 
(including external service providers)
Number of psychologists Total number of psychologists on the basis of full-time equivalents 
(including external service providers)
Number of dentists Total number of dentists on the basis of full-time equivalents (including 
external service providers)
Pharmacists and oral 
health-care workers
Pharmacists Pharmacists working in prisons (including external service providers)
Dental hygienists/oral health 
promoters
Dental hygienists and/or oral health promoters working in prisons 
(including external service providers)
SECTION 3 – PRISON ENvIRONMENT
Grouping Indicator name in database Specification for metadata
Smoke-free cells Smoke-free cells Availability of smoke-free cells
Meal preparation Meal preparation Meals produced in a centralized kitchen (institutional kitchen where meals 
are prepared for prisoners in one or more prison facilities)
Alternative food 
systems
Availability of alternative food 
systems
i) Self-cook kitchen areas (at least half of inmates can cook for themselves); 
ii) refrigerators in at least half of cells or housing units where prisoners can 
store personal food items; iii) prison store/commissary/vending machines 
with fresh food (e.g. fruit); iv) prison store/commissary/vending machines 
with packaged snacks; and v) other food options
SECTION 4 – RISK FACTORS FOR ILL HEALTH
Grouping Indicator name in database Specification for metadata
Prevalence of 
selected risk factors
Tobacco use Number and percentage of tobacco smokers identified on or close to 
reception among persons admitted to prisons
Overweight Number of cases and prevalence of overweight (body mass index (BMI) > 25) 
identified on or close to reception among persons admitted to prison
Obesity Number of cases and prevalence of obesity BMI > 30 identified on or close 
to reception among persons admitted to prison
Raised blood pressure
Number of cases and prevalence of raised blood pressure (individuals 
above 18 years of age with a systolic blood pressure of > 140 mmHg and/
or a diastolic blood pressure of > 90 mmHg on or close to reception among 
persons admitted to prison
Current injecting drug use
Number of cases and prevalence of current injecting drug use (in the  
past 30 days) identified on or close to reception among persons admitted 
to prison
Ever injecting drug use Number of cases and prevalence of ever injecting drug use identified on or 
close to reception among persons admitted to prison
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SECTION 4 – RISK FACTORS FOR ILL HEALTH contd
Grouping Indicator name in database Specification for metadata
Substance use 
screening
Urine/sputum screening for 
illicit drug use screening
Urine/sputum screening for illicit drug use on or close to reception to 
prison
Availability of screening for  
illicit drug use
Availability of non-mandatory urine/sputum screening on or close to 
reception
Screening for harmful use of 
alcohol Screening for harmful alcohol use on or close to reception
Use of alcohol screening tool Use of recognized screening tool for harmful alcohol use
Biomedical testing 
for drug use
Number of prisoners screened 
for drug use
Number of prisoners biomedically tested for drug use on or close to 
reception (if screening for illicit drug use is available)
Percentage of prisoners 
screened for drug use
Percentage of prisoners biomedically tested for drug use on or close to 
reception (if screening for illicit drug use is available)
SECTION 5 – DISEASE SCREENING
Grouping Indicator name in database Specification for metadata
Mental health 
screening
Mental health screening Screening for severe mental health disorders by a trained mental health 
professional on or close to reception
Diversion to mental health 
treatment
Diversion to a mental health treatment institution as a result of screening 
on or close to reception
Oral health 
screening
Screening for oral health 
problems





Sexually transmitted infection 
(STIs) screening Screening for STIs on or close to reception
Availability of HIV testing Availability of non-mandatory HIV testing
Hepatitis B testing Hepatitis B testing on or close to reception
Availability of hepatitis B 
testing Availability of non-mandatory hepatitis B testing on or close to reception
Hepatitis C testing Hepatitis C testing on or close to reception
Availability of hepatitis C 
testing
Availability of non-mandatory hepatitis C testing on or close to 
reception
HIV testing HIV testing on or close to reception
HIv testing 
coverage
Number of prisoners tested 
for HIV Number of prisoners tested for HIV on or close to reception
Percentage of prisoners tested 
for HIV Percentage of prisoners tested for HIV on or close to reception
Prevalence of 
syphilis
Number of syphilis cases 
among male prisoners
Number of cases of syphilis among males admitted to prison on or close 
to reception
Percentage of syphilis cases 
among male prisoners
Percentage of cases of syphilis among males admitted to prison on or 
close to reception
Number of syphilis cases 
among female prisoners
Number of cases of syphilis among females admitted to prison on or 
close to reception
Percentage of syphilis cases 
among female prisoners
Percentage of cases of syphilis among females admitted to prison on 
or close to reception
Prevalence of 
chlamydia
Number of chlamydia cases 
among male prisoners
Number of cases of chlamydia among males admitted to prison on or 
close to reception
Percentage of chlamydia cases 
among male prisoners
Percentage of cases of chlamydia among males admitted to prison on 
or close to reception
Number of chlamydia cases 
among female prisoners
Number of cases of chlamydia among females admitted to prison on 
or close to reception
Percentage of chlamydia cases 
among female prisoners
Percentage of cases of chlamydia among females admitted to prison 
on or close to reception
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SECTION 5 – DISEASE SCREENING contd
Grouping Indicator name in database Specification for metadata
Prevalence of HIv
Number of positive HIV tests 
among males
Number of HIV positive tests among males admitted to prison on or close 
to reception
Prevalence of positive HIV tests 
among males
Prevalence of HIV positive tests among males admitted to prison on or 
close to reception
Number of positive HIV tests 
among females
Number of HIV positive tests among females admitted to prison on or 
close to reception
Prevalence of positive HIV tests 
among females
Prevalence of HIV positive tests among females admitted to prison on or 
close to reception
Number of HIV tests in 
tuberculosis (TB) cases Number of all TB cases with pulmonary localization tested for HIV
Prevalence of HIV tests in TB 
cases Prevalence of all TB cases with pulmonary localization tested for HIV
Number of TB cases positive 
for HIV Number of all TB cases with pulmonary localization positive for HIV
Percentage of TB cases positive 
for HIV Prevalence of all TB cases with pulmonary localization positive for HIV
Prevalence of 
hepatitis B
Percentage of prisoners tested 
for anti-HBs
Percentage of prisoners tested for hepatitis B (anti-HBs – hepatitis B 
surface antibody test) on or close to reception
Positive anti-HB tests Positive hepatitis B tests (anti-HBs – hepatitis B surface antibody test) 
on or close to reception
Percentage of prisoners tested 
for HBsAg
Percentage of prisoners tested for hepatitis B (HBsAg – hepatitis B 
surface antigen test) on or close to reception
Positive HBsAg tests Positive hepatitis B tests (HBsAg – hepatitis B surface antigen test) on 
or close to reception
Prevalence of 
hepatitis C
Percentage of prisoners tested 
for anti-HCVs
Percentage of prisoners tested for hepatitis C (anti-HCVs – hepatitis C 
surface antibody test) on or close to reception
Positive anti-HCV tests Positive hepatitis C tests (anti-HCVs – hepatitis C surface antibody 
test) on or close to reception
Percentage of prisoners tested 
for HCV-PCR
Percentage of prisoners tested for hepatitis C (HCV-PCR – hepatitis C 
polymerase chain reaction test) on or close to reception
Positive HCV-PCR tests Positive hepatitis C tests (HCV-PCR – hepatitis C polymerase chain 
reaction test) on or close to reception
Prevalence of TB
Number of new/relapse TB 
testing
Number of prisoners tested for new/relapse TB with pulmonary 
localization
Percentage of new/relapse TB 
testing
Percentage of prisoners tested for new/relapse TB with pulmonary 
localization
Number of new/relapse TB 
cases detected Number of new/relapse TB cases with pulmonary localization detected
Percentage of new/relapse TB 
cases detected
Percentage of new/relapse TB cases with pulmonary localization 
detected
Number of prisoners 
completing TB treatment Number of prisoners completing a treatment programme for TB
Number of MDR tests in new/
relapse TB cases
Number of new/relapse TB cases with pulmonary localization tested 
for MDR (multidrug-resistance)
Number of MDR cases in new/
relapse TB cases
Number of cases of MDR (multidrug-resistance) detected among 
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SECTION 6 – PREvENTION
Grouping Indicator name in database Specification for metadata
Drug-related 
problems
Availability of needle/syringe 
programmes
Needle/syringe exchange programmes for people who inject drugs 
implemented in prisons
Drug-free units Drug-free units in prisons
Responsibility for infectious 
diseases prevention
Ministry of Health or a public health authority responsible for prevention 
of infectious diseases in prisons
Drug-free units Number of prisoners in  
drug-free units Number of prisoners in drug-free units
STIs and  
bloodborne
viruses
Availability of disinfectants Disinfectants (tablet and/or liquid solution) that can be used for cleaning 
of syringes, razors, tattoo equipment etc. available in prisons
Disinfectants free of charge Disinfectants available free of charge
Condoms available Condoms available in prisons
Condoms free of charge Condoms available free of charge
Lubricants available Lubricants available in prisons




Hepatitis B vaccination 
availability Availability of full vaccination course against hepatitis B in prisons
Hepatitis B vaccination 




Number of hepatitis B 
vaccinations Number of prisoners fully vaccinated against hepatitis B
Percentage of hepatitis B 
vaccinations Percentage of prisoners fully vaccinated against hepatitis B
Possibility for 
family/partner visits
Possibility for family/partner 
visits
Non-supervised family/partner visits possible (including the possibility for 
sexual intercourse)
Community health 
links Community health links
Links between the prison health system and the community health 
system for health treatments (concerning e.g. HIV or hepatitis treatment, 
treatment for drug dependence) of prisoners
SECTION 7 – TREATMENT
Grouping Indicator name in database Specification for metadata
Drug treatments  
and overdose 
prevention
Available treatments for drug 
dependence
Availability of: i) maintenance treatment (e.g. long-term opioid agonist 
pharmacotherapy); ii) detoxification treatment (e.g. short-term opioid 
agonist pharmacotherapy); iii) detoxification without opioid agonists 
treatment (e.g. benzodiazepine pharmacotherapy); iv) mutual support/
self-help treatment (e.g. 12-step programme, Alcoholics Anonymous, 
Narcotics Anonymous); v) open-access treatment (e.g. computer-
based interventions); vi) other psychosocial treatment (e.g. cognitive 
behavioural therapy); and vi) other treatment
Drug-deaths prevention 
guidelines
National guidelines on prevention of post-release drug-related deaths 
(e.g. covering referral to community services, counselling on increased 




Prisoners in substitution 
treatment
Number of prisoners in substitution treatment (treatment with opioid 




eligibility Population eligible for substitution treatment
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SECTION 7 – TREATMENT contd
Grouping Indicator name in database Specification for metadata
Mental health
Mental health treatment 
guidelines
National guidelines for the treatment of severe mental health disorders 
among prisoners
Mental health support access
Access to mental health support for prisoners (e.g. a peer support worker, 
Samaritans, counselling or psychological treatments) delivered by 
specialized health staff
HIv and hepatitis C
HIV treatment Number of prisoners in antiretroviral treatment for HIV, if available
Hepatitis C treatment Number of prisoners in antiviral treatment for hepatitis C, if available
SECTION 8 – MORTALITY
Indicator name in database Specification for metadata
Total number of deaths Total number of deaths among all prisoners (regardless of the location (within or outside 
prison) at which death occurred)
Number of male deaths Number of male deaths among all prisoners (regardless of the location (within or outside 
prison) at which death occurred)
Number of female deaths Number of female deaths among all prisoners (regardless of the location (within or outside 
prison) at which death occurred)
Number of underage deaths Number of deaths among prisoners below 18 years of age (regardless of the location (within 
or outside prison) at which death occurred)
Number of suicides Number of deaths by suicide among all prisoners (regardless of the location (within or outside 
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ANNEX 2. PARTICIPATING MEMBER STATES
Member State ISOa code Member State ISOa code
Albania ALB Malta MLT
Armenia ARM Monaco MCO
Azerbaijan AZE Montenegro MNE
Belgium BEL Netherlands NLD
Bosnia and Herzegovina BIH Norway NOR
Bulgaria BGR Poland POL
Croatia HRV Portugal PRT
Cyprus CYP Republic of Moldova MDA
Czechia CZE Romania ROU
Denmark DNK Russian Federation RUS
Estonia EST Serbia SRB
Finland FIN Slovakia SVK
France FRA Slovenia SVN
Georgia GEO Spain ESP
Germany DEU Sweden SWE
Iceland ISL Switzerland CHE
Ireland IRL Tajikistan TJK
Italy ITA United Kingdom of Great Britain  
and Northern Ireland
GBR
Latvia LVA Ukraine UKR
Lithuania LTU
a  ISO: International Organization for Standardization.  

















ANNEX 3. SUMMARY OF DATA PROvIDED BY COUNTRIES IN THIS REPORT
1 PRISON POPULATION STATISTICS    
Question 
number in 















ALB, AZE, BEL, BGR, BIH, CHE, CZE, DNK, ESP, 
EST, FIN, FRA, GBR, GEO, HRV, IRL, ISL, ITA, 
LTU, LVA, MDA, MLT, MNE, NLD, POL, PRT, 
RUS, SRB, SVK, SVN, SWE, UKR
33 (85) 5 (13) 1 (3) NA
2015
ALB, BEL, BIH, CHE, CZE, DNK, ESP, EST, FIN, 
FRA, GBR, GEO, HRV, IRL, ISL, ITA, LTU, LVA, 
MCO, MLT, MNE, NLD, NOR, POL, PRT, ROU, 
RUS, SRB, SVK, SVN, SWE, UKR
32 (82) 6 (15) 1 (3) NA
2014
ALB, BEL, BIH, CHE, CZE, DNK, ESP, EST, FIN, 
FRA, GBR, GEO, HRV, IRL, ISL, ITA, LTU, LVA, 
MCO, MLT, MNE, NLD, NOR, POL, PRT, ROU, 
RUS, SRB, SVK, SVN, SWE, TJK, UKR
33 (85) 6 (15) NA NA
 Total daily number of people incarcerated
1.2
2016
ALB, AZE, BEL, BGR, BIH, CHE, CZE, DNK, ESP, 
EST, FIN, FRA, GBR, GEO, HRV, IRL, ISL, ITA, 
LTU, LVA, MDA, MLT, MNE, NLD, POL, PRT, 
RUS, SRB, SVK, SVN, SWE, UKR
32 (82) 4 (10) 3 (8) NA
2015
ALB, AZE, BEL, BGR, BIH, CHE, CZE, DNK, ESP, 
EST, FIN, FRA, GBR, GEO, HRV, IRL, ISL, ITA, 
LTU, LVA, MDA, MLT, MNE, NLD, POL, PRT, 
ROU, RUS, SRB, SVK, SVN, SWE, UKR
33 (85) 3 (8) 3 (8) NA
2014
ALB, AZE, BEL, BGR, BIH, CHE, CZE, DNK, ESP, 
EST, FIN, FRA, GBR, GEO, HRV, IRL, ISL, ITA, 
LTU, LVA, MDA, MLT, MNE, NLD, POL, PRT, 
ROU, RUS, SRB, SVK, SVN, SWE, TJK, UKR
34 (87) 3 (8) 2 (5) NA
 Total daily number of people remanded/unsentenced
1.3
2016
ALB, BEL, BGR, BIH, CHE, CZE, DNK, ESP, EST, 
FIN, FRA, GEO, HRV, IRL, ISL, ITA, LTU, LVA, 
MLT, POL, PRT, RUS, SVK, SVN, SWE, UKR
26 (67) 9 (23) 4 (10) NA
2015
ALB, BEL, BGR, BIH, CHE, CZE, DNK, ESP, EST, 
FIN, GBR, GEO, HRV, IRL, ISL, ITA, LTU, LVA, 
MLT, MNE, POL, PRT, ROU, RUS, SVK, SVN, 
SWE, UKR
28 (72) 8 (21) 3 (8) NA
2014
ALB, BEL, BGR, BIH, CHE, CZE, DNK, ESP, EST, 
FIN, GBR, GEO, HRV, IRL, ISL, ITA, LTU, LVA, 
MLT, POL, PRT, ROU, RUS, SVK, SVN, SWE, 
UKR
27 (69) 8 (21) 4 (10) NA
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1 PRISON POPULATION STATISTICS contd    
Question 
number in 












 Total daily number of  females incarcerated
1.4
2016
ALB, AZE, BEL, BGR, BIH, CHE, CZE, DNK, ESP, 
EST, FIN, FRA, GBR, GEO, HRV, IRL, ISL, ITA, 
LTU, LVA, MLT, NLD, POL, PRT, RUS, SRB, SVK, 
SVN, SWE, UKR
30 (77) 6 (15) 3 (8) NA
2015
ALB, AZE, BEL, BGR, BIH, CHE, CZE, DNK, ESP, 
EST, FIN, GBR, GEO, HRV, IRL, ISL, ITA, LTU, 
LVA, MLT, MNE, NLD, POL, PRT, ROU, RUS, 
SRB, SVK, SVN, SWE, UKR
31 (79) 4 (10) 4 (10) NA
2014
ALB, AZE, BEL, BGR, BIH, CHE, CZE, DNK, ESP, 
EST, FIN, GBR, GEO, HRV, IRL, ISL, ITA, LTU, 
LVA, MLT, NLD, POL, PRT, ROU, RUS, SRB, SVK, 
SVN, SWE, TJK, UKR
31 (79) 4 (10) 4 (10) NA
 Total daily number of young people (under 18 years) incarcerated
1.5
2016
ALB, AZE, BEL, BGR, BIH, CHE, CZE, DNK, ESP, 
EST, FIN, FRA, GEO, HRV, IRL, ISL, ITA, LTU, 
LVA, MLT, MNE, NLD, PRT, RUS, SRB, SVK, 
SVN, SWE, UKR
29 (74) 7 (18) 3 (8) NA
2015
ALB, AZE, BEL, BGR, BIH, CHE, CZE, DNK, ESP, 
EST, FIN, FRA, GEO, HRV, IRL, ISL, ITA, LTU, 
LVA, MLT, MNE, NLD, PRT, RUS, SRB, SVK, 
SVN, SWE, UKR
28 (72) 8 (21) 3 (8) NA
2014
ALB, BEL, BGR, BIH, CHE, CZE, DNK, ESP, EST, 
FIN, GBR, GEO, HRV, IRL, ISL, ITA, LTU, LVA, 
NLD, PRT, ROU, RUS, SRB, SVK, SVN, SWE, 
UKR
27 (69) 8 (21) 4 (10) NA
 Total daily number of seniors (over 55 years) incarcerated
1.6
2016 ALB, BEL, BGR, BIH, DNK, ESP, EST, FIN, GEO, IRL, ISL, ITA, PRT, RUS, SRB, SVN
16 (41) 18 (46) 5 (13) NA
2015 ALB, BEL, BGR, BIH, DNK, ESP, EST, FIN, GEO, IRL, ISL, ITA, PRT, ROU, RUS, SRB, SVN
17 (44) 17 (44) 5 (13) NA
2014 ALB, BEL, BGR, BIH, DNK, ESP, EST, FIN, GEO, IRL, ISL, ITA, PRT, ROU, RUS, SRB, SVN
17 (44) 17 (44) 5 (13) NA
 Total daily number of people from ethnic/racial minorities incarcerated
1.7
2016 ALB, BEL, BGR, BIH, DNK, ESP, EST, FIN, GEO, IRL, ISL, ITA, PRT, RUS, SRB, SVN
16 (41) 18 (46) 5 (13) NA
2015 ALB, BEL, BGR, BIH, DNK, ESP, EST, FIN, GEO, IRL, ISL, ITA, PRT, ROU, RUS, SRB, SVN
17 (44) 17 (44) 5 (13) NA
2014 ALB, BEL, BGR, BIH, DNK, ESP, EST, FIN, GEO, IRL, ISL, ITA, PRT, ROU, RUS, SRB, SVN
17 (44) 17 (44) 5 (13) NA
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2 PRISON HEALTH-CARE SYSTEMS    
Question 
number in 












 Prison health-care governance
2.1 Prison health-care 
authority All countries
39 (100) NA NA NA
2.2 Prison health-care 
budget administration
ALB, ARM, AZE, BEL, BGR, BIH, CHE, CYP, CZE, 
DNK, ESP, EST, FIN, FRA, GBR, GEO, HRV, IRL, 
ISL, ITA, LTU, LVA, MCO, MDA, MLT, MNE, 
NLD, NOR, POL, PRT, ROU, RUS, SRB, SVK, 
SVN, SWE, TJK, UKR
38 (97) 1 (3) NA NA
2.3 Prison health-care 
funding source
ALB, ARM, AZE, BEL, BGR, BIH, CHE, CZE, 
DNK, ESP, EST, FIN, FRA, GBR, GEO, HRV, IRL, 
ISL, ITA, LTU, LVA, MCO, MDA, MLT, MNE, 
NLD, NOR, POL, PRT, ROU, RUS, SRB, SVK, 
SVN, SWE, TJK, UKR
37 (95) 1 (3) 1 (3) NA
 Health-care costs paid by people who are incarcerated
2.3.1
General health services
ALB, ARM, AZE, BEL, BGR, BIH, CHE, CZE, 
DNK, ESP, EST, FIN, FRA, GBR, GEO, HRV, IRL, 
ISL, ITA, LTU, LVA, MCO, MDA, MLT, MNE, 
NLD, NOR, POL, PRT, ROU, RUS, SRB, SVK, 
SVN, SWE, TJK, UKR
37 (95) 1 (3) 1 (3) NA
Prescription medication
ALB, ARM, AZE, BEL, BGR, BIH, CHE, CYP, CZE, 
DNK, ESP, EST, FIN, FRA, GBR, GEO, HRV, IRL, 
ISL, ITA, LTU, LVA, MCO, MDA, MLT, MNE, 
NLD, NOR, POL, PRT, ROU, RUS, SRB, SVK, 
SVN, SWE, TJK, UKR
38 (97) 1 (3) NA NA
Other expenses
ALB, ARM, AZE, BEL, BGR, BIH, CHE, CZE, 
DNK, ESP, EST, FIN, FRA, GBR, GEO, HRV, IRL, 
ISL, ITA, LTU, LVA, MCO, MDA, MNE, NLD, 
NOR, POL, PRT, ROU, RUS, SRB, SVK, SVN, 
SWE, TJK, UKR
36 (92) 1 (3) 2 (5) NA
 Responsibilities of Ministry of Health or other public health authorities
2.4
Assessment of prison 
health services
ALB, ARM, AZE, BEL, BGR, BIH, CHE, CYP, CZE, 
DNK, ESP, EST, FIN, FRA, GBR, GEO, HRV, IRL, 
ISL, ITA, LTU, LVA, MCO, MDA, MLT, MNE, 
NLD, NOR, POL, PRT, RUS, SRB, SVK, SVN, 
SWE, TJK, UKR
37 (95) 1 (3) 1 (3) NA
Inspection of hygiene, 
nutrition and living 
conditions
ALB, ARM, AZE, BEL, BGR, BIH, CHE, CYP, CZE, 
DNK, ESP, EST, FIN, FRA, GBR, GEO, HRV, IRL, 
ISL, ITA, LTU, LVA, MCO, MDA, MLT, MNE, 
NLD, NOR, POL, PRT, RUS, SRB, SVK, SVN, 
SWE, TJK, UKR
37 (95) 1 (3) 1 (3) NA
2.5 Medical documentation 
inspection
ALB, ARM, AZE, BEL, BGR, BIH, CHE, CYP, CZE, 
DNK, ESP, EST, FIN, FRA, GBR, GEO, HRV, IRL, 
ISL, ITA, LTU, LVA, MCO, MDA, MLT, MNE, 
NLD, NOR, POL, PRT, ROU, RUS, SRB, SVK, 
SVN, SWE, TJK, UKR
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2 PRISON HEALTH-CARE SYSTEMS contd
Question 
number in 












 National health-care complaints system
2.6 Existence of system and 
availability in prisons
ALB, AZE, BEL, BIH, CHE, CYP, CZE, DNK, ESP, 
EST, FIN, FRA, GBR, GEO, HRV, IRL, ISL, ITA, 
LTU, LVA, MCO, MDA, MLT, MNE, NLD, NOR, 
POL, PRT, ROU, RUS, SRB, SVK, SVN, SWE, TJK, 
UKR
36 (92) 3 (8) NA NA
 Number of staff in prison (full-time equivalents)
2.7
Prison staff
ALB, BEL, BGR, BIH, CHE, CZE, ESP, EST, FIN, 
GEO, HRV, IRL, ISL, ITA, LTU, LVA, MCO, MDA, 
NOR, POL, PRT, ROU, RUS, SRB, SVK, SVN, 
SWE
27 (69) 8 (21) 4 (10) NA
Health-care staff
ALB, AZE, BEL, BGR, BIH, CHE, CZE, ESP, EST, 
FIN, FRA, GEO, HRV, IRL, ITA, LTU, LVA, MDA, 
MLT, MNE, NOR, POL, PRT, ROU, RUS, SRB, 
SVK, SWE, UKR
29 (74) 7 (18) 3 (8) NA
2.8
Physicians
ALB, AZE, BEL, BGR, BIH, CZE, ESP, EST, FIN, 
FRA, GEO, HRV, IRL, ISL, ITA, LTU, LVA, MCO, 
MDA, MLT, MNE, NOR, POL, PRT, ROU, RUS, 
SRB, SVK, SVN, SWE, UKR
31 (79) 7 (18) 1 (3) NA
Psychiatrists
ALB, AZE, BEL, BGR, BIH, CYP, CZE, DNK, ESP, 
EST, FIN, FRA, GEO, HRV, IRL, ISL, ITA, LTU, 
LVA, MCO, MDA, MLT, MNE, NLD, POL, PRT, 
ROU, RUS, SVK, SVN, SWE, UKR
32 (82) 7 (18) NA NA
Psychologists
ALB, BEL, BGR, BIH, CYP, ESP, EST, FIN, FRA, 
GEO, HRV, IRL, ISL, ITA, LTU, LVA, MCO, MDA, 
MLT, MNE, POL, PRT, ROU, RUS, SVK, SVN, 
SWE, UKR
28 (72) 11 (28) NA NA
Dentists
ALB, AZE, BEL, BIH, CZE, ESP, EST, FIN, FRA, 
GBR, GEO, HRV, IRL, ISL, LTU, LVA, MCO, MLT, 
MNE, PRT, ROU, RUS, SVK, SVN, SWE, UKR
26 (67) 10 (26) 3 (8) NA
 Existence of staff working in prison
2.8.1 Pharmacists
ALB, ARM, AZE, BEL, BGR, BIH, CYP, CZE, DNK, 
ESP, EST, FIN, FRA, GBR, GEO, HRV, IRL, ISL, 
LTU, LVA, MCO, MDA, MLT, NLD, NOR, POL, 
PRT, ROU, RUS, SRB, SVK, SVN, SWE, TJK, UKR
35 (90) 4 (10) NA NA
2.8.2
Dental hygienists 
and/or oral health 
promoters
ALB, ARM, AZE, BEL, BGR, CYP, CZE, DNK, ESP, 
EST, FIN, FRA, GBR, GEO, HRV, IRL, ISL, LTU, 
LVA, MCO, MDA, MLT, MNE, NLD, POL, PRT, 
RUS, SRB, SVK, SVN, SWE, TJK, UKR
33 (85) 6 (15) NA NA


















ALB, AZE, BEL, BGR, BIH, CZE, DNK, ESP, EST,
FIN, FRA, GBR, GEO, HRV, IRL, ISL, ITA, LTU,
LVA, MCO, MDA, MLT, MNE, NLD, POL, PRT,
ROU, RUS, SVK, SVN, SWE, UKR
32 (82) 7 (18) NA NA
3.2 Meals produced
in centralized kitchens
ALB, ARM, AZE, BEL, BGR, BIH, CYP, CZE,
DNK, ESP, EST, FIN, FRA, GBR, GEO, HRV, IRL,
ISL, ITA, LTU, LVA, MCO, MDA, MLT, MNE,
NLD, NOR, POL, PRT, ROU, RUS, SRB, SVK,
SVN, SWE, TJK, UKR
37 (95) 2 (5) NA NA
3.2.1 Alternative food
systems available
ALB, AZE, BEL, BGR, BIH, CYP, CZE, DNK, ESP,
EST, FIN, GEO, HRV, IRL, ISL, ITA, LTU, LVA,
MCO, MDA, MLT, MNE, NLD, NOR, POL, PRT,
ROU, RUS, SVN, SWE, TJK, UKR
32 (82) 6 (15) 1 (3) NA
4 RISK FACTORS FOR ILL HEALTH
Question 
number in 












 Prevalence of risk factors on admission
4.1 Tobacco-smoking ESP, EST, MCO, RUS, SVK 5 (13) 32 (82) 2 (5) NA
4.2
Overweight (body
mass index (BMI) > 25) DNK, MNE, RU
3 (8) 36 (92) NA NA
Obesity (BMI > 30) MNE 1 (3) 37 (95) 1 (3) NA
4.3 Raised blood pressure AZE, BGR, BIH, DNK, FIN, MDA, MNE, RUS 8 (21) 29 (74) 2 (5) NA
 Urine/sputum testing
4.4 Availability
ALB, BEL, BGR, BIH, CYP, CZE, DNK, ESP, EST,
FIN, FRA, GBR, GEO, HRV, IRL, ISL, ITA, LTU,
LVA, MCO, MDA, MLT, MNE, NLD, POL, PRT,
ROU, RUS, SRB, SVK, SVN, SWE, TJK
33 (85) 6 (15) NA NA
4.4.1 Testing if not
mandatory
ALB, BEL, BGR, BIH, ESP, EST, FIN, FRA, GBR,
GEO, HRV, IRL, ISL, ITA, LTU, MCO, MNE, NLD,
POL, PRT, ROU, RUS, SRB, SVK, SVN
25 (64) 1 (3) 2 (5) 11 (28)
 Biomedical testing for substance use
4.4.2 Percentage tested BIH, ESP, GEO, HRV, MCO, SVK 6 (15) 29 (74) 4 (10) NA
 Prevalence of injecting drug use identified on admission
4.4.3 Current injecting drug
use ESP, GBR, ITA, MCO, SVK
5 (13) 32 (82) 2 (5) NA
4.4.4 Lifetime injecting drug
use AZE, ESP, GBR, HRV, ITA
5 (13) 28 (72) 6 (15) NA
 Screening for harmful alcohol use on admission
4.5 Availability
ALB, AZE, BEL, BGR, BIH, CYP, CZE, DNK, ESP,
EST, FIN, FRA, GBR, GEO, HRV, IRL, ISL, ITA,
LTU, LVA, MCO, MDA, MLT, MNE, NLD, POL,
PRT, ROU, RUS, SVK, SVN, SWE, TJK, UKR
34 (87) 5 (13) NA NA
4.5.1 Use of a recognized
screening tool
BGR, CYP, DNK, ESP, EST, FIN, FRA, GBR, HRV,
IRL, ISL, ITA, LVA, NLD, POL, ROU, SVK, SVN,
SWE
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5 DISEASE SCREENING ON ADMISSION
Question 
number in 












 Severe mental health disorder screening on admission
5.1 Availability
ALB, AZE, BEL, BGR, BIH, CYP, CZE, DNK, ESP, 
EST, FIN, FRA, GBR, GEO, HRV, IRL, ISL, ITA, 
LTU, LVA, MCO, MDA, MLT, MNE, NLD, NOR, 
POL, PRT, ROU, RUS, SRB, SVK, SWE, TJK, UKR
35 (90) 4 (10) NA NA
5.1.1
Availability of diversion 
to a mental health 
institution resulting 
from screening
ALB, AZE, BEL, BIH, CHE, CYP, CZE, DNK, ESP, 
EST, FIN, FRA, GBR, GEO, HRV, IRL, ISL, ITA, 
LTU, LVA, MCO, MDA, MLT, MNE, NLD, NOR, 
POL, PRT, ROU, RUS, SRB, SVK, SVN, SWE, TJK, 
UKR
29 (74) NA 1 (3) 9 (23)
 Screening for other communicable and noncommunicable diseases on admission
5.2 Availability of oral 
health screening
ALB, AZE, BEL, BGR, BIH, CZE, DNK, ESP, EST, 
FIN, FRA, GBR, GEO, HRV, IRL, ISL, ITA, LTU, 
LVA, MCO, MDA, MLT, MNE, NLD, NOR, POL, 
PRT, ROU, RUS, SRB, SVK, SVN, SWE, TJK, UKR
35 (90) 3 (8) 1 (3) NA
5.3
Availability of sexualy 
transmitted infection  
screening
ALB, AZE, BEL, BGR, BIH, CYP, CZE, DNK, ESP, 
EST, FIN, FRA, GBR, GEO, HRV, IRL, ISL, ITA, 
LTU, LVA, MCO, MDA, MNE, NLD, POL, PRT, 
ROU, RUS, SRB, SVK, SVN, SWE, TJK, UKR
34 (87) 5 (13) NA NA
 Prevalence of syphilis on admission
5.3.1
Men AZE, BGR, BIH, DNK, ESP, GEO, HRV, ISL, MNE, RUS
10 (26) 25 (64) 4 (10) NA
Women ALB, AZE, BGR, BIH, DNK, ESP, GEO, HRV, LVA, MDA, MNE, RUS
12 (31) 26 (67) 1 (3) NA
 Prevalence of chlamydia on admission
5.3.2
Men ALB, BIH, FIN, HRV, MDA, MNE 6 (15) 32 (82) 1 (3) NA
Women ALB, BIH, FIN, HRV, MNE 5 (13) 32 (82) 2 (5) NA
 HIv testing on admission
5.4 Availability
ALB, AZE, BEL, BGR, BIH, CZE, DNK, ESP, EST, 
FIN, FRA, GBR, GEO, HRV, IRL, ISL, ITA, LTU, 
LVA, MCO, MDA, MLT, MNE, NLD, NOR, POL, 
PRT, ROU, RUS, SRB, SVK, SVN, SWE, TJK, UKR
35 (90) 3 (8) 1 (3) NA
5.4.1 Testing if not 
mandatory
ALB, AZE, BEL, BGR, BIH, CZE, DNK, ESP, EST, 
FIN, FRA, GBR, GEO, HRV, IRL, ISL, ITA, LTU, 
MDA, MLT, MNE, NLD, NOR, POL, PRT, ROU, 
SRB, SVK, SVN, SWE, UKR
31 (79) NA 1 (3) 7 (18)
5.4.2 Percentage tested BGR, BIH, ESP, FIN, GBR, GEO, HRV, LVA, MCO, MDA, MNE, RUS, SVK, SWE, UKR
15 (38) 19 (49) 5 (13) NA
5.4.3
Prevalence of positive 
tests in males
AZE, BGR, DNK, ESP, GEO, ISL, MCO, MDA, 
MNE, PRT, UKR
11 (28) 23 (59) 5 (13) NA
Prevalence of positive 
tests in females
AZE, BGR, ESP, GEO, MCO, MLT, MNE, PRT, 
ROU
9 (23) 26 (67) 4 (10) NA
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 Hepatitis B testing on admission
5.5 Availability
ALB, AZE, BEL, BGR, BIH, CHE, CZE, DNK, ESP, 
EST, FIN, FRA, GBR, GEO, HRV, IRL, ISL, ITA, 
LTU, LVA, MCO, MDA, MLT, MNE, NLD, NOR, 
POL, PRT, ROU, RUS, SRB, SVK, SVN, SWE, TJK, 
UKR
36 (92) 2 (5) 1 (3) NA
5.5.1 Testing if not 
mandatory
ALB, AZE, BEL, BGR, BIH, DNK, ESP, EST, FIN, 
FRA, GBR, GEO, HRV, IRL, ISL, ITA, LTU, LVA, 
MDA, MLT, MNE, NLD, POL, PRT, ROU, RUS, 
SRB, SVK, SVN, SWE, UKR
31 (79) NA 2 (5) 6 (15)
5.5.2
Percentage tested for 
anti-HB ESP, MDA, MLT, MNE
4 (10) 27 (69) 5 (13) 3 (8)
Percentage of positive 
anti-HB tests AZE, ESP, FIN, MDA, MLT, MNE
6 (15) 27 (69) 3 (8) 3 (8)
Percentage tested  
for HBsAg ESP, GEO, MCO, MDA, MLT, MNE, PRT, SVK
8 (21) 25 (64) 3 (8) 3 (8)
Percentage of positive 
HBsAg tests ALB, ESP, GEO, MCO, MLT, MNE, PRT, SVK
8 (21) 26 (67) 2 (5) 3 (8)
 Hepatitis C testing on admission
5.6 Availability
ALB, AZE, BEL, BGR, BIH, CZE, DNK, ESP, EST, 
FIN, FRA, GBR, GEO, HRV, IRL, ISL, ITA, LTU, 
LVA, MCO, MDA, MLT, MNE, NLD, NOR, POL, 
PRT, ROU, RUS, SRB, SVK, SVN, SWE, TJK, UKR
35 (90) 3 (8) 1 (3) NA
5.6.1 Testing if not 
mandatory
ALB, AZE, BEL, BGR, BIH, DNK, ESP, EST, FIN, 
FRA, GBR, GEO, HRV, IRL, ISL, ITA, LTU, LVA, 
MDA, MLT, MNE, NLD, NOR, POL, PRT, ROU, 
RUS, SRB, SVK, SVN, SWE, UKR
32 (82) NA 1 (3) 6 (15)
5.6.2
Percentage tested for 
Anti-HCV
ESP, EST, GBR, GEO, MDA, MNE, PRT, SVK, 
SWE
9 (23) 21 (54) 5 (13) 4 (1)
Percentage of positive 
anti-HCV tests
AZE, ESP, EST, FIN, GBR, GEO, MDA, MNE, PRT, 
SVK, SWE
11 (28) 21 (54) 3 (8) 4 (1)
Percentage tested for 
HCV RNA ESP, GBR, GEO, MLT, MNE, SWE
6 (15) 25 (64) 4 (10) 4 (1)
Percentage of positive 
HCVRNA tests ALB, ESP, GBR, GEO, MDA, MLT, MNE, SWE
8 (21) 24 (62) 3 (8) 4 (1)
 Tuberculosis (TB) testing
5.7
Percentage tested for 
new or relapse TB
AZE, BGR, ESP, EST, GEO, MCO, MLT, MNE, 
NLD, PRT, RUS, SVK
12 (31) 23 (59) 4 (10) NA
Percentage of new 
or relapse TB cases 
detected
BEL, BGR, ESP, FIN, GEO, MDA, MNE, NLD, 
PRT, SVK
10 (26) 20 (51) 7 (18) 2 (5)
5.7.3
Percentage of TB cases 
tested for HIV
BEL, ESP, GEO, LTU, MCO, MDA, MLT, MNE, 
NLD, PRT, RUS, SVK, UKR
13 (33) 21 (54) 5 (13) NA
Percentage of TB cases 
positive for HIV ESP, GBR, GEO, LTU, NLD, SVK, UKR
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6 PREvENTION OF INFECTION
Question 
number in 












6.1 Infectious disease 
prevention
ALB, ARM, AZE, BEL, BGR, BIH, CHE, CZE, 
DNK, ESP, EST, FIN, FRA, GBR, GEO, HRV, IRL, 
ISL, ITA, LTU, LVA, MCO, MDA, MLT, MNE, 
NLD, NOR, POL, PRT, ROU, RUS, SRB, SVK, 
SVN, SWE, TJK,  UKR





ALB, ARM, AZE, BEL, BGR, BIH, CHE, CYP, 
CZE, DNK, ESP, EST, FIN, FRA, GBR, GEO, HRV, 
IRL, ISL, ITA, LTU, LVA, MCO, MDA, MLT, NLD, 
NOR, POL, PRT, ROU, RUS, SRB, SVK, SVN, 
SWE, UKR
36 (92) 3 (8) NA NA
 Disinfectants
6.3 Availability
ALB, ARM, AZE, BEL, BGR, BIH, CZE, DNK, ESP, 
FIN, FRA, GBR, GEO, HRV, IRL, ISL, ITA, LTU, 
LVA, MCO, MDA, MLT, NOR, POL, PRT, ROU, 
RUS, SRB, SVK, SVN, SWE, TJK, UKR
33 (85) 6 (15) NA NA
6.3.1 Availability free of 
charge
ARM, BGR, DNK, ESP, FIN, FRA, GBR, GEO, 
ITA, LTU, NOR, PRT, RUS, TJK, UKR
15 (38) NA NA 24 (62)
 Condoms
6.4 Availability
ALB, ARM, AZE, BEL, BGR, BIH, CHE, CYP, CZE, 
DNK, ESP, EST, FIN, FRA, GBR, GEO, HRV, IRL, 
ISL, ITA, LTU, LVA, MCO, MDA, MLT, MNE, 
NLD, NOR, POL, PRT, ROU, SRB, SVK, SVN, 
SWE, UKR
36 (92) 3 (8) NA NA
6.4.1 Availability free of 
charge
ALB, ARM, AZE, BEL, BGR, BIH, CHE, CZE, 
DNK, ESP, EST, FIN, FRA, GBR, GEO, HRV, ISL, 
LTU, MDA, MLT, NLD, NOR, PRT, ROU, SRB, 
SVK, SVN, SWE, UKR
29 (74) 1 (3) NA 9 (23)
 Lubricants
6.5 Availability
ALB, ARM, AZE, BEL, BGR, BIH, CYP, CZE, ESP, 
EST, FRA, GBR, GEO, HRV, IRL, ISL, ITA, LVA, 
MCO, MDA, MLT, MNE, POL, PRT, ROU, SRB, 
SVK, SVN, SWE, UKR
30 (77) 9 (23) NA NA
6.5.1 Availability free of 
charge
ARM, AZE, BEL, BGR, BIH, ESP, FRA, GBR, 
MDA, MLT, ROU, SVK, SWE, UKR
14 (36) 1 (3) NA 24 (62)
 Non-supervised family/partner visits
6.6 Availability
ALB, ARM, AZE, BEL, BGR, BIH, CYP, CZE, DNK, 
ESP, EST, FIN, FRA, GBR, GEO, HRV, IRL, ISL, 
ITA, LTU, LVA, MCO, MDA, MLT, MNE, NLD, 
NOR, POL, PRT, ROU, RUS, SRB, SVK, SVN, 
SWE, TJK, UKR
37 (95) 2 (5) NA NA
 Drug-free units
6.7 Availability
ALB, ARM, BEL, BGR, BIH, CZE, DNK, ESP, EST, 
FIN, FRA, GBR, GEO, HRV, IRL, ISL, LTU, LVA, 
MCO, MDA, MLT, MNE, NLD, PRT, ROU, SRB, 
SVK, SVN, UKR
29 (74) 7 (18) 3 (8) NA
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 Hepatitis B vaccine
6.8 Availability
ALB, ARM, AZE, BEL, BGR, BIH, CHE, CZE, 
DNK, ESP, EST, FIN, FRA, GBR, GEO, HRV, IRL, 
ISL, ITA, LTU, LVA, MCO, MDA, MLT, NLD, 
NOR, POL, PRT, ROU, RUS, SRB, SVK, SVN, 
SWE, UKR
35 (90) 2 (5) 2 (5) NA
 Continuity of care
6.9
Links between prison 
health and community 
health systems
ALB, ARM, AZE, BEL, BGR, BIH, CHE, CZE, ESP, 
EST, FIN, FRA, GBR, GEO, HRV, IRL, ISL, ITA, 
LTU, LVA, MCO, MDA, MLT, MNE, NLD, NOR, 
POL, PRT, ROU, RUS, SRB, SVK, SVN, SWE, TJK, 
UKR




















AZE, BGR, DNK, ESP, GEO, ISL, MCO, MDA, 
MNE, PRT, UKR ARM, AZE, BEL, BGR, BIH, 
CHE, CYP, DNK, ESP, EST, FIN, FRA, GBR, GEO, 
HRV, IRL, ISL, ITA, LTU, LVA, MCO, MDA, MLT, 
MNE, NLD, NOR, POL, PRT, ROU, RUS, SRB, 
SVK, SVN, SWE, UKR
35 (90) 2 (5) 2 (5) NA
Detoxification 
treatment available
ARM, AZE, BEL, BGR, CHE, CYP, DNK, ESP, EST, 
FIN, FRA, GBR, GEO, HRV, IRL, ISL, ITA, LTU, 
LVA, MCO, MDA, MLT, MNE, NLD, NOR, POL, 
PRT, ROU, RUS, SRB, SVK, SVN, SWE, UKR




ALB, ARM, AZE, BEL, BGR, BIH, CHE, CYP, CZE, 
DNK, ESP, EST, FIN, FRA, GBR, GEO, HRV, IRL, 
ISL, ITA, LTU, LVA, MCO, MDA, MLT, MNE, 
NLD, NOR, POL, PRT, ROU, RUS, SRB, SVK, 
SVN, SWE, UKR




ALB, ARM, AZE, BEL, BGR, BIH, CHE, CYP, CZE, 
DNK, ESP, EST, FIN, FRA, GBR, GEO, HRV, IRL, 
ISL, ITA, LTU, LVA, MCO, MDA, MLT, MNE, 
NLD, NOR, POL, PRT, ROU, RUS, SRB, SVK, 
SVN, SWE, UKR
37 (95) 2 (5) NA NA
Other psychosocial 
treatment available
ALB, ARM, AZE, BEL, BGR, BIH, CHE, CYP, CZE, 
DNK, ESP, EST, FIN, FRA, GBR, GEO, HRV, IRL, 
ISL, ITA, LTU, LVA, MCO, MDA, MLT, MNE, 
NLD, NOR, POL, PRT, ROU, RUS, SRB, SVK, 
SVN, SWE, UKR
37 (95) 2 (5) NA NA
Other treatment 
available
ALB, ARM, AZE, BEL, BGR, BIH, CHE, CYP, CZE, 
DNK, ESP, EST, FIN, FRA, GBR, GEO, HRV, IRL, 
ISL, ITA, LTU, LVA, MCO, MDA, MLT, MNE, 
NLD, NOR, POL, PRT, ROU, RUS, SRB, SVK, 
SVN, SWE, UKR
37 (95) 2 (5) NA NA
7.2.1 Population eligible for 
substitution treatment
ALB, ARM, BEL, BGR, BIH, CHE, CYP, CZE, 
DNK, ESP, EST, FIN, FRA, GBR, HRV, IRL, ISL, 
ITA, LVA, MCO, MDA, MLT, MNE, NLD, NOR, 
POL, PRT, ROU, SRB, SVN, SWE, UKR
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 National guidelines for treatment for substance use and mental health
7.3




ALB, ARM, AZE, BEL, BGR, BIH, CHE, CZE, 
DNK, ESP, EST, FIN, FRA, GBR, GEO, HRV, IRL, 
ISL, ITA, LTU, LVA, MCO, MDA, MLT, MNE, 
NLD, NOR, POL, PRT, ROU, SRB, SVK, SVN, 
SWE, UKR
35 (90) 2 (5) 2 (5) NA
7.4
National guidelines for 
treatment in prison for 
severe mental illness
ALB, ARM, AZE, BEL, BGR, BIH, CHE, CYP, CZE, 
DNK, ESP, EST, FIN, FRA, GBR, GEO, HRV, IRL, 
ISL, ITA, LTU, LVA, MCO, MDA, MNE, NLD, 
NOR, POL, PRT, ROU, RUS, SRB, SVK, SVN, 
SWE, TJK, UKR
37 (95) 1 (3) 1 (3) NA
 Mental health support
7.5 Accessible in prisons
ALB, AZE, BEL, BGR, BIH, CYP, CZE, DNK, ESP, 
EST, FIN, FRA, GBR, GEO, HRV, IRL, ISL, ITA, 
LTU, LVA, MCO, MDA, MLT, MNE, NLD, NOR, 
POL, PRT, ROU, RUS, SRB, SVK, SVN, SWE, TJK, 
UKR
















 Number of deaths
8.1 Total
ALB, AZE, BEL, BGR, BIH, CHE, CZE, ESP, EST, 
FIN, FRA, GBR, GEO, HRV, IRL, ISL, ITA, LTU, 
LVA, MCO, MDA, MLT, MNE, NLD, POL, PRT, 
ROU, RUS, SRB, SVK, SVN, SWE, UKR
33 (85) 5 (13) 1 (3) NA
8.1.1
Males
ALB, AZE, BGR, BIH, CZE, ESP, EST, GBR, GEO, 
HRV, IRL, ISL, ITA, LTU, LVA, MCO, MDA, MLT, 
MNE, NLD, PRT, ROU, RUS, SVK, SVN, SWE, 
UKR
27 (69) 11 (28) 1 (3) NA
Females
ALB, AZE, BGR, BIH, CZE, ESP, EST, GBR, GEO, 
HRV, IRL, ISL, ITA, LTU, LVA, MCO, MDA, MLT, 
MNE, NLD, PRT, ROU, RUS, SVK, SVN, SWE, 
UKR
27 (69) 11 (28) 1 (3) NA
Young people  
(under 18 years)
ALB, AZE, BGR, BIH, CZE, ESP, EST, GBR, GEO, 
HRV, IRL, ISL, ITA, LTU, LVA, MCO, MDA, MLT, 
MNE, NLD, PRT, ROU, RUS, SVK, SVN, SWE, 
UKR
26 (67) 12 (31) 1 (3) NA
8.1.2 Suicide
ALB, AZE, BEL, BGR, BIH, CHE, CZE, ESP, EST, 
FRA, GBR, GEO, HRV, ISL, ITA, LTU, LVA, MCO, 
MDA, MLT, MNE, NLD, POL, PRT, ROU, RUS, 
SRB, SVK, SVN, SWE, UKR
31 (79) 7 (18) 1 (3) NA
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Reference group provided  
(n = provided prevalence 
estimate)












4.1 Tobacco-smoking 5 5 NA 4 NA 1a
4.2
Overweight (body 
mass index (BMI)) 3 1
2 1 NA NA
Obesity (BMI > 30) 1 0 1 NA NA NA
4.3 Raised blood pressure 8 7 1 5 1 NA
4.4.3 Current injecting drug 
use 5 5
0 4 NA 1
4.4.4 Lifetime injecting drug 
use 5 5
0 5 2 1
5.4.3
Prevalence of positive 
HIV tests in males 11 10
1 7 1 2
Prevalence of positive 
HIV tests in females 9 9
0 7 1 1
5.5.2
Percentage tested for 
anti-HB 4 3
1 3 NA NA
Percentage tested for 
HBsAg 8 7
1 7 NA NA
5.6.2
Percentage tested for 
anti-HCV 9 9
0 9 NA NA
Percentage tested for 
HCV RNA 6 6
0 6 NA NA
5.7
Percentage tested 
for new or relapse 
tuberculosis (TB)
12 11 NA 9 1 1b
Percentage of new 
or relapse TB cases 
detected
10 10 NA 7 2 1
5.7.3
Percentage of TB cases 
tested for HIV 13 12
1 10 NA 2
Percentage of TB cases 
positive for HIV 7 6
1 4 NA 2c
a Refers to people in pre-trial detention. b Refers to people who were born in countries with a high prevalence of TB (greater than 10 cases per 100 000 people); people who had a 
 past TB diagnosis; people who had previously served a sentence in a foreign prison in the past five years; or people who had clinical symptoms. c Refers to people who are 
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ANNEX 5. SUMMARY OF COUNTRIES PROvIDING RESPONSES 
1 PRISON POPULATION STATISTICS    
Indicator or calculation n Countries
Provided complete data across prison population 
statistics in 2016 6 ALB, BIH, DNK, IRL, ISL, ITA
Provided data to calculate change in incarceration rate 
from 2014 to 2016 32
ALB, AZE, BEL, BGR, BIH, CHE, CZE, DNK, ESP, EST, FIN, FRA, 
GBR, GEO, HRV, IRL, ISL, ITA, LTU, LVA, MDA, MLT, MNE, NLD, 
POL, PRT, RUS, SRB, SVK, SVN, SWE, UKR
Provided data to calculate overcrowding 30
ALB, BEL, BGR, BIH, CHE, CZE, DNK, ESP, EST, FIN, FRA, GBR, 
GEO, HRV, IRL, ISL, ITA, LTU, LVA, MLT, MNE, NLD, POL, PRT, 
RUS, SRB, SVK, SVN, SWE, UKR
 Provided data for subgroup proportions compared with total prison population (2016)
People from ethnic/minority backgrounds 8 ALB, BIH, CHE, DNK, IRL, ISL, ITA, NLD
People who are senior (over 55 years of age) 16 ALB, BEL, BGR, BIH, DNK, ESP, EST, FIN, GEO, IRL, ISL, ITA, PRT, RUS, SRB, SVN
Young people (under 18 years of age) 29
ALB, AZE, BEL, BGR, BIH, CHE, CZE, DNK, ESP, EST, FIN, FRA, 
GEO, HRV, IRL, ISL, ITA, LTU, LVA, MLT, MNE, NLD, PRT, RUS, 
SRB, SVK, SVN, SWE, UKR
Females 30
ALB, AZE, BEL, BGR, BIH, CHE, CZE, DNK, ESP, EST, FIN, FRA, 
GBR, GEO, HRV, IRL, ISL, ITA, LTU, LVA, MLT, NLD, POL, PRT, 
RUS, SRB, SVK, SVN, SWE, UKR
Unsentenced/remanded people 26
ALB, BEL, BGR, BIH, CHE, CZE, DNK, ESP, EST, FIN, FRA, GEO, 
HRV, IRL, ISL, ITA, LTU, LVA, MLT, POL, PRT, RUS, SVK, SVN, 
SWE, UKR
2 PRISON HEALTH-CARE SYSTEMS    
Indicator or calculation n Countries
 Prison health-care service authorities    
Ministry of Justice 23 ALB, ARM, BEL, BIH, CHE, DEU, EST, HRV, IRL, LTU, LVA, MCO, MDR, MNE, NLD, POL, PRT, SRB, SVK, SWE, CHE, TJK, UKR
Ministry of Health and other public health authorities 17 ALB, ARM, CHE, CYP, CZE, DNK, ESP, FIN, FRA, GBR, ISL, ITA, LTU, MLT, NOR, SVK, SVN
Health-care department of the prison system 8 ALB, AZE, CZE, DNK, GEO, ISL, MDA, ROU
Ministry of Interior 2 ESP, CHE
Other 3 CZEa, ISLb, MLTc
Combination (more than one authority) 11 ALB, ARM, CHE, CZE, DNK, ESP, ISL, LTU, MDA, MLT, SVK
a Under authority of prison health service but authorized by Ministry of Justice. b Some staff are employed under the Prison and Probation Administration. 
c Department of Correctional Services, care of Ministry for Home Affairs and Security.
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2 PRISON HEALTH-CARE SYSTEMS contd
Indicator or calculation n Countries
 Administration of the budget for prison health-care services    
Ministry of Justice 22 ALB, ARM, BEL, BGR, BIH, CHE, CZE, EST, HRV, LTU, LVA, MCO, MDA, MNE, NLD, POL, PRT, SRB, SVK, SWE, TJK, UKR
Ministry of Health and other public health authorities 13 ALB, ARM, CHE, CYP, ESP, FIN, FRA, GBR, ISL, ITA, LTU, NOR, SVN
Health-care department of the prison system 8 ALB, DNK, GEO, IRL, ISL, MLT, ROU, RUS
Ministry of Interior 2 CHE, ESP
Other 3 AZEa, BIHb, MLTc, ROUd, SVKe
Combination (more than one authority) 10 ALB, ARM, BIH, CHE, ESP, ISL, LTU, MLT, ROU, SVK
a Main Medical Management. b Independent  prison  budgets. c Department of Corrective Services, care of the Ministry of Home Affairs and Security. d Prison hospitals. 
e Health insurance companies and independent prison budgets.
 Funding sources of prison health systems    
Ministry of Justice budget 17 ALB, BEL, BGR, BIH, CHE, DNK, EST, IRL, NLD, POL, PRT, ROU, SRB, SVK, SWE, TJK, UKR
Government budget 17 ALB, ARM, AZE, FIN, FRA, GBR, GEO, HRV, ISL, LTU, LVA, MCO, MDA, MNE, NOR, RUS, SVN
Ministry of Health and other public health authorities 
budget 10 ALB, CHE, DNK, ESP, FIN, FRA, GBR, ITA, MLT, SWE
Compulsory health insurance 6 ALB, CHE, CZE, HRV, ROU, SVK
Ministry of Interior budget 5 CHE, ESP, MDA, ROU, TJK
Other 3 ALB, BIHa, UKR
a Independent prison budgets.
 Responsibilities of Ministry of Health or other public health authorities    
Assessment of prison health services 17 CYP, EST, FIN, FRA, GBR, ISL, ITA, LTU, LVA, NOR, PRT, RUS, SVK, SVN, SWE, TJK, UKR
Inspection of hygiene, nutrition and living conditions 22 ALB, BIH, CYP, CZE, DNK, EST, FIN, FRA, GBR, HRV, ITA, LTU, LVA, MLT, NLD, NOR, POL, PRT, SRB, SVK, SWE, TJK
Infectious disease prevention 17 BEL, BIH, FIN, FRA, GBR, HRV, ISL, ITA, LVA, MCO, MLT, NOR, RUS, SRB, SVK, SVN, TJK
 National health-care complaints system  
Exists and is available in prisons 33
ALB, AZE, BEL, BIH, CYP, CZE, DNK, ESP, EST, FIN, FRA, GBR, 
GEO, HRV, IRL, ISL, ITA, LTU, LVA, MCO, MDA, MLT, NLD, NOR, 
POL, PRT, RUS, SRB, SVK, SVN, SWE, TJK, UKR
 Links between prison health systems and community health systems for health care  
Exist 33
ALB, ARM, BGR, BIH, CHE, CZE, ESP, EST, FIN, FRA, GBR, GEO, 
HRV, IRL, ISL, ITA, LTU, LVA, MDA, MLT, MNE, NLD, NOR, POL, 
















76   
STATUS REPORT ON PRISON HEALTH IN THE WHO EUROPEAN REGION 
2 PRISON HEALTH-CARE SYSTEMS contd
Indicator or calculation n Countries
 Provided data for prison staff ratios (2014–2016)  
Prison staff 23 ALB, BGR, BIH, CHE, CZE, ESP, EST, FIN, GEO, HRV, IRL, ISL, ITA, LTU, LVA, MDA, POL, PRT, ROU, RUS, SRB, SVK, SWE
Health-care staff 25
ALB, AZE, BGR, BIH, CHE, CZE, ESP, EST, FIN, FRA, GEO, HRV, 
IRL, LTU, LVA, MDA, MNE, POL, PRT, ROU, RUS, SRB, SVK, 
SWE, UKR
Physicians 25
ALB, AZE, BGR, BIH, CZE, ESP, EST, FIN, FRA, GEO, HRV, IRL, 
ISL, LTU, LVA, MDA, MNE, POL, PRT, ROU, RUS, SRB, SVK, SWE, 
UKR
Psychologists 22 ALB, BGR, BIH, ESP, EST, FIN, FRA, GEO, HRV, IRL, ISL, LTU, LVA, MDA, MNE, POL, PRT, ROU, RUS, SVK, SWE, UKR
Psychiatrists 25
ALB, AZE, BGR, BIH, CZE, ESP, EST, FIN, FRA, GEO, HRV, IRL, 
ISL, LTU, LVA, MDA, MNE, NLD, POL, PRT, ROU, RUS, SVK, 
SWE, UKR
Dentists 21 ALB, AZE, BIH, CZE, ESP, EST, FIN, FRA, GEO, HRV, IRL, ISL, LTU, LVA, MNE, PRT, ROU, RUS, SVK, SWE, UKR
3 PRISON ENvIRONMENT
Indicator or calculation n Countries
Smoke-free cells available in at least some prisons 25
ALB, AZE, BGR, BIH, CZE, DNK, ESP, EST, FIN, FRA, GBR, GEO, 
HRV, IRL, ISL, ITA, LTU, MCO, POL, PRT, ROU, RUS, SVK, SVN, 
SWE
Meals produced in centralized kitchens in at least 
some prisons 35
ALB, ARM, AZE, BEL, BGR, BIH, CYP, CZE, DNK, ESP, EST, FIN, 
FRA, GBR, GEO, HRV, IRL, ITA, LTU, LVA, MCO, MDA, MLT, 
MNE, NLD, NOR, POL, PRT, ROU, RUS, SRB, SVK, SVN, SWE, 
UKR
 Alternative food systems available  
Self-cook kitchens 12 DNK, FIN, GEO, ISL, LTU, MDA, NLD, NOR, POL, ROU, RUS, SWE
Refrigerators 18 ALB, AZE, BEL, BIH, CYP, CZE, DNK, FIN, ITA, LTU, LVA, MCO, MDA, MLT, MNE, NLD, NOR, RUS
Fresh food 18 AZE, BIH, CZE, DNK, ESP, FIN, GEO, HRV, ISL, ITA, LTU, LVA, MDA, MNE, NOR, POL, PRT, RUS
Packaged snacks 17 AZE, CZE, DNK, EST, GEO, HRV, ISL, ITA, LTU, LVA, NOR, POL, PRT, RUS, SVN, SWE, UKR
Other 12 BGR, BIH, GEO, IRL, ISL, LTU, MCO, MLT, ROU, SWE, TJK, UKR
4 RISK FACTORS FOR ILL HEALTH
Indicator or calculation n Countries
Screening for harmful alcohol use on admission 
available in at least some prisons 20
BGR, CYP, DNK, ESP, EST, FIN, FRA, GBR, HRV, IRL, ISL, ITA, 
LVA, NLD, POL, ROU, SVK, SVN, SWE, TJK
Urine/sputum testing available on admission but not 
mandatory 12 BEL, BGR, GBR, GEO, HRV, ISL, ITA, POL, PRT, SRB, SVK, SVN
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5 DISEASE SCREENING ON ADMISSION
Indicator or calculation n Countries
Screening for severe mental health disorders on 
admission available in at least some prisons 30
ALB, AZE, BGR, BIH, CYP, ESP, EST, FIN, FRA, GBR, GEO, HRV, 
IRL, ISL, ITA, LTU, MCO, MDA, MLT, MNE, NLD, NOR, POL, 
ROU, RUS, SRB, SVK, SWE, TJK, UKR
At least some diversion to mental health treatment 
available as a result of this screening 24
ALB, AZE, BGR, BIH, CYP, ESP, EST, FRA, GBR, GEO, HRV, IRL, 
ISL, ITA, LTU, MCO, MDA, MLT, MNE, NLD, ROU, SRB, TJK, UKR
Oral health screening available in at least some 
prisons 23
ALB, AZE, BGR, BIH, CZE, ESP, FRA, GBR, GEO, IRL, LTU, MCO, 
MDA, MLT, NOR, POL, PRT, ROU, RUS, SRB, SVK, TJK, UKR
Screening for sexually transmitted infection on 
admission available in at least some prisons 25
ALB, BEL, BGR, BIH, CYP, CZE, ESP, EST, FIN, FRA, GBR, GEO, 
IRL, ITA, LTU, LVA, MCO, MDA, NLD, PRT, ROU, RUS, SVK, TJK, 
UKR
 HIv testing requirements on admission  
Testing available on admission but not mandatory 14 ALB, BEL, BGR, BIH, CZE, DNK, HRV, IRL, ITA, MNE, NLD, NOR, POL, SRB
Testing routinely offered on an opt-out basis but not 
mandatory 16
AZE, ESP, EST, FIN, FRA, GBR, GEO, ISL, LTU, MDA, MLT, PRT, 
ROU, SVN, SWE, UKR
 Hepatitis B testing requirements on admission  
Testing available on admission but not mandatory 15 ALB, BEL, BIH, DNK, EST, HRV, IRL, ISL, ITA, LVA, MNE, NLD, POL, SRB, SWE
Testing routinely offered on an opt-out basis but not 
mandatory 11 AZE, ESP, FIN, FRA, GBR, GEO, MDA, MLT, PRT, ROU, SVN
Available but other arrangements in place 2 BGRa, LTUb
 Hepatitis C testing requirements on admission
Testing available on admission but not mandatory 14 ALB, BEL, BIH, DNK, EST, HRV, IRL, ITA, MLT, MNE, NLD, NOR, POL, SRB
Testing routinely offered on an opt-out basis but not 
mandatory 12 AZE, ESP, FIN, FRA, GBR, GEO, ISL, MDA, PRT, ROU, SVN, SWE
Available but other arrangements in place 2 BGRa, LTUb
a Offered by a nongovernmental organization. b Only conducted on the basis of clinical suspicion.
6 PREvENTION OF INFECTION
Indicator or calculation n Countries
Disinfectants available in at least some prisons 15 ARM, BGR, DNK, ESP, FIN, FRA, GBR, GEO, ITA, LTU, NOR, PRT, RUS, TJK, UKR
Disinfectants available free of charge 13 ARM, DNK, ESP, FIN, FRA, GBR, GEO, LTU, NOR, PRT, RUS, TJK, UKR
Condoms available in at least some prisons 29
ALB, ARM, AZE, BEL, BGR, BIH, CHE, CZE, DNK, ESP, EST, FIN, 
FRA, GBR, GEO, HRV, ISL, LTU, MDA, MLT, NLD, NOR, PRT, 
ROU, SRB, SVK, SVN, SWE, UKR
Condoms available free of charge 25
ALB, ARM, AZE, BEL, BGR, BIH, CHE, DNK, ESP, EST, FIN, FRA, 
GBR, GEO, ISL, LTU, MDA, NLD, NOR, PRT, ROU, SRB, SVN, 
SWE, UKR
Lubricants available in at least some prisons 14 ARM, AZE, BEL, BGR, BIH, ESP, FRA, GBR, MDA, MLT, ROU, SVK, SWE, UKR
Lubricants available free of charge 12 ARM, AZE, BEL, BGR, BIH, ESP, FRA, GBR, MDA, ROU, SWE, UKR
Non-supervised family visits available in at least some 
prisons 30
ALB, ARM, AZE, BEL, BIH, CZE, DNK, ESP, EST, FIN, FRA, GEO, 
HRV, ISL, LTU, LVA, MDA, MLT, MNE, NLD, NOR, POL, PRT, 
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6 PREvENTION OF INFECTION contd
Indicator or calculation n Countries
 Hepatitis B vaccine availability in prisons  
Offered to all eligible people who are incarcerated 11 ESP, FIN, FRA, GBR, IRL, ISL, ITA, MLT, PRT, RUS, SWE
Offered to at-risk groups 4 ARM, CZE, EST, NOR
Available on request 7 BEL, CZE, DNK, HRV, SRB, SVK, SVN
Other 5 CHEa, ISL, MLT, NLDb, POL
a Available to a number of groups, including anyone who asks for the vaccine, people who use drugs, people from high-endemic regions, sex workers, as well as people 
 who are incarcerated and staff who face professional risks. b Offered to men who have sex with men.
7 TREATMENT
Indicator or calculation n Countries
Drug-free units available in at least some prisons 16 ALB, ARM, BEL, CZE, DNK, ESP, EST, FIN, GBR, ISL, LTU, MDA, PRT, SRB, SVK, SVN
Available mental health support delivered by 
specialized staff 35
ALB, AZE, BEL, BGR, BIH, CYP, CZE, DNK, ESP, EST, FIN, FRA, 
GBR, GEO, HRV, IRL, ISL, ITA, LTU, LVA, MDA, MLT, MNE, NLD, 
NOR, POL, PRT, ROU, RUS, SRB, SVK, SVN, SWE, TJK, UKR
 Available treatments for substance use 
Maintenance treatment 28
ARM, BEL, BGR, BIH, CHE, DNK, ESP, EST, FIN, FRA, GBR, HRV, 
IRL, ISL, ITA, LVA, MCO, MDA, MLT, MNE, NLD, NOR, POL, PRT, 
ROU, SRB, SVN, SWE
Detoxification treatment 25
BEL, BGR, CHE, CYP, DNK, ESP, EST, FIN, FRA, GBR, HRV, IRL, 
ISL, ITA, MCO, MLT, NLD, NOR, POL, PRT, ROU, SRB, SVN, SWE, 
UKR
Detoxification without opioid agonists 26
AZE, BEL, BIH, CYP, CZE, ESP, EST, FIN, GBR, GEO, HRV, IRL, 
ISL, ITA, LTU, MNE, NOR, POL, PRT, ROU, RUS, SRB, SVK, SVN, 
SWE, UKR
Mutual support/self-help treatment 20 BGR, CHE, DNK, ESP, EST, FRA, GBR, HRV, IRL, ISL, ITA, LTU, LVA, MLT, MNE, PRT, ROU, RUS, SVN, SWE
Other psychosocial treatment 24 AZE, CHE, CYP, CZE, DNK, ESP, EST, FIN, GBR, HRV, ISL, ITA, LTU, LVA, MLT, NOR, POL, PRT, ROU, RUS, SRB, SVK, SVN, SWE
Other treatment 6 ALB, CHE, ESP, GBRa, IRLb, RUSc
Substitution treatment available for people who are 
sentenced or in pre-trial detention 26
ALB, ARM, BEL, CHE, CYP, DNK, ESP, EST, FIN, FRA, GBR, IRL, 
ISL, ITA, LVA, MDA, MLT, MNE, NLD, NOR, POL, PRT, SRB, SVN, 
SWE, UKR
 National guidelines for treatment 
Guidelines on post-release substance-use-related 
death exist 18
ALB, ARM, BEL, BIH, CHE, CZE, DNK, FRA, GBR, IRL, ITA, MDA, 
MLT, NLD, NOR, PRT, ROU, SVN
Guidelines for treatment in prison for severe mental 
illness exist 23
ALB, ARM, AZE, BGR, BIH, CYP, DNK, ESP, FRA, GBR, GEO, ITA, 
LTU, MDA, MNE, NLD, NOR, PRT, ROU, RUS, SVK, TJK, UKR
a Eye movement desensitization and reprocessing in some prisons. b Music therapy programmes. c Rehabilitation programmes.
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8 MORTALITY
Indicator or calculation n Countries
Provided complete data to calculate mortality rate 
(2014–2016) 31
ALB, AZE, BEL, BGR, BIH, CHE, CZE, ESP, EST, FIN, GBR, GEO, 
HRV, IRL, ISL, ITA, LTU, LVA, MDA, MLT, MNE, NLD, POL, PRT, 
ROU, RUS, SRB, SVK, SVN, SWE, UKR
Provided complete data to calculate mortality rate for 
men (2014–2016) 24
ALB, AZE, BGR, BIH, CZE, ESP, EST, GBR, GEO, HRV, IRL, ISL, 
ITA, LTU, LVA, MLT, NLD, PRT, ROU, RUS, SVK, SVN, SWE, UKR
Provided complete data to calculate mortality rate for 
women (2014–2016) 24
ALB, AZE, BGR, BIH, CZE, ESP, EST, GBR, GEO, HRV, IRL, ISL, 
ITA, LTU, LVA, MLT, NLD, PRT, ROU, RUS, SVK, SVN, SWE, UKR
Provided complete data to calculate mortality rate for 
young people (2014–2016) 24
ALB, AZE, BGR, BIH, CZE, EST, GBR, GEO, HRV, IRL, ISL, ITA, 
LTU, LVA, MLT, MNE, NLD, PRT, ROU, RUS, SVK, SVN, SWE, 
UKR
Provided complete data to calculate ratio of deaths by 
suicide and suicide rate (2014–2016) 30
ALB, AZE, BEL, BGR, BIH, CHE, CZE, ESP, EST, FRA, GBR, GEO, 
HRV, ISL, ITA, LTU, LVA, MDA, MLT, MNE, NLD, POL, PRT, ROU, 
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